{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":53,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":53,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"c4752fabaa7c","filters":{"venue":"BioDrugs"}},"results":[{"id":"W2277879584","doi":"10.1007/s40259-016-0162-9","title":"Trastuzumab in the Treatment of Breast Cancer","year":2016,"lang":"en","type":"review","venue":"BioDrugs","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":230,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Norwegian Institute of Public Health; Direktorat Jenderal Pendidikan Tinggi; Sanofi Pasteur; Johns Hopkins Bloomberg School of Public Health; University of Illinois at Urbana-Champaign; National Institutes of Health; Seqirus; Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja; Ministero della Salute; National Health and Medical Research Council; AstraZeneca; Amarin Corporation; Bundesministerium für Bildung und Forschung; Novavax; Sanofi; Comunidad de Madrid; Boston Scientific Corporation; Public Health England; University of Calgary; Arizona State University; GlaxoSmithKline; Bristol-Myers Squibb; Australian Government; Pfizer; Lembaga Pengelola Dana Pendidikan; Johns Hopkins University; Edwards Lifesciences; Bill and Melinda Gates Foundation; Instituto de Salud Carlos III; Amgen; Damon Runyon Cancer Research Foundation; Medical Research Council; Teva Pharmaceutical Industries; South African Medical Research Council; Seoul National University; U.S. Department of Veterans Affairs; Genentech; U.S. Environmental Protection Agency","keywords":"Trastuzumab; Pertuzumab; Medicine; Lapatinib; Breast cancer; Cardiotoxicity; Cancer; Disease; Oncology; Targeted therapy; Internal medicine; Pharmacology; Chemotherapy","authors":[{"name":"Sofia Maximiano","is_ca":false},{"name":"Paulo Magalhães","is_ca":false},{"name":"Mara Pereira Guerreiro","is_ca":false},{"name":"Manuel Morgado","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1386676677073322,"gpt":0.4761857603569551,"spread":0.337518092649623,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006767204,0.0009088516,0.001931957,0.002399624,0.0002084013,0.0009851636,0.0008751166,0.001013978,0.003541812],"category_scores_gemma":[0.0009819958,0.0002909772,0.0006017548,0.002257132,0.0004104078,0.001080005,0.0007754232,0.001858872,0.001155809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006616839,"about_ca_system_score_gemma":0.0009574449,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001541525,"about_ca_topic_score_gemma":0.003536819,"domain_scores_codex":[0.9997869,0.00004355324,0.000035773,0.00003232361,0.00007680229,0.00002476676],"domain_scores_gemma":[0.9996655,0.0001819338,0.00005888785,0.000007706467,0.00005941229,0.00002656684],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001350024,0.00006698688,0.0001042216,0.02259624,0.0001654534,0.0001403438,0.00003863789,0.000385366,0.001092793,0.002271991,0.02202445,0.9509786],"study_design_scores_gemma":[0.00009430505,0.0001581364,0.0006934064,0.008471993,0.0004427209,0.0009588999,0.00005440756,0.0001519404,0.0004877443,0.001736134,0.9867284,0.00002192408],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00005737072,0.9993703,0.00003892804,0.0001090942,0.00008602891,0.00000266685,0.000009374323,0.000002510406,0.0003237922],"genre_scores_gemma":[0.0004396165,0.998989,0.0000625571,0.0001342859,0.00008559346,0.000002738562,0.00001608973,6.65057e-7,0.0002693653],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003541812,"threshold_uncertainty_score":0.01184851,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2079402257","doi":"10.2165/00063030-200115050-00001","title":"C2 Monitoring Strategy for Optimising Cyclosporin Immunosuppression from the Neoral??* Formulation","year":2001,"lang":"en","type":"review","venue":"BioDrugs","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Immunosuppression; Medicine; Therapeutic drug monitoring; Nephrotoxicity; Trough level; Transplantation; Kidney transplantation; Urology; Ciclosporin; Pharmacology; Internal medicine; Drug; Kidney; Tacrolimus","authors":[{"name":"Gary Levy","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2002765864096752,"gpt":0.4437927799303807,"spread":0.2435161935207055,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003110266,0.0004557106,0.0004556826,0.0005498653,0.0001528587,0.0004531339,0.0005162184,0.0005333971,0.002362765],"category_scores_gemma":[0.0001983498,0.00009106218,0.0001984936,0.0004843276,0.0001884238,0.0004058407,0.000190361,0.0004995967,0.0007899104],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004863004,"about_ca_system_score_gemma":0.0005306673,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001223045,"about_ca_topic_score_gemma":0.001302516,"domain_scores_codex":[0.9999132,0.00002030536,0.000008299984,0.00001640855,0.00003100973,0.00001071588],"domain_scores_gemma":[0.9999362,0.00001657522,0.00002035395,0.000003797521,0.00001823836,0.000004786948],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006811445,0.0002230458,0.000245635,0.00472323,0.00003652017,0.000354514,0.00002929356,0.0008330742,0.09413755,0.002922769,0.006162378,0.8896509],"study_design_scores_gemma":[0.0002581126,0.001904177,0.002197128,0.001055287,0.0002420119,0.003793031,0.00006884924,0.001623173,0.3055193,0.001199321,0.6820982,0.0000414261],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03495793,0.9241226,0.01273864,0.001156836,0.0007156786,0.0002985001,0.0003218633,0.0001645274,0.0255234],"genre_scores_gemma":[0.1818806,0.7695251,0.01830321,0.001746422,0.0004485469,0.0003150425,0.000686446,0.00004418041,0.02705051],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002362765,"threshold_uncertainty_score":0.007904232,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016399234","doi":"10.2165/00063030-200923010-00002","title":"MicroRNA-Based Therapeutics for Cancer","year":2009,"lang":"en","type":"review","venue":"BioDrugs","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":159,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"microRNA; Biology; Translation (biology); Oncomir; Cancer; Signal transduction; Computational biology; Cancer research; Bioinformatics; Gene; Messenger RNA; Cell biology; Genetics","authors":[{"name":"Vivien Wang","is_ca":false},{"name":"Wei Wu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04809701016503418,"gpt":0.3556908438159273,"spread":0.3075938336508931,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009773429,0.001474359,0.001878928,0.001574047,0.0003891195,0.0008320446,0.001094789,0.001679255,0.003825096],"category_scores_gemma":[0.0008093802,0.0004851246,0.0005512909,0.001425198,0.0009027765,0.001347738,0.0009060843,0.003089774,0.002966321],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000818424,"about_ca_system_score_gemma":0.0006573256,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005401884,"about_ca_topic_score_gemma":0.001680719,"domain_scores_codex":[0.9997751,0.00004282459,0.00002425425,0.00004246673,0.00008914777,0.00002608882],"domain_scores_gemma":[0.9997873,0.0001116614,0.00002719662,0.00001014782,0.00003979405,0.00002401032],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001562708,0.0001616661,0.00008917292,0.003962094,0.00008399452,0.0003379193,0.00004530888,0.0007700644,0.01080356,0.0101454,0.0474228,0.9260218],"study_design_scores_gemma":[0.00007410044,0.0001633024,0.0002613854,0.0005809159,0.00008871453,0.001074738,0.0000255368,0.0004308949,0.003785917,0.003954171,0.989537,0.00002331296],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003588278,0.9917598,0.00234714,0.000555563,0.001156574,0.00002336112,0.00003240646,0.00004278379,0.00372351],"genre_scores_gemma":[0.003469805,0.9883298,0.002403818,0.0007236555,0.0006505096,0.00006109512,0.00009127158,0.00001157221,0.004258496],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003825096,"threshold_uncertainty_score":0.01279622,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2550419061","doi":"10.1007/s40259-016-0204-3","title":"Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors","year":2016,"lang":"en","type":"review","venue":"BioDrugs","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":117,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Ontario Institute for Cancer Research","keywords":"Immune system; Immunology; Medicine; Adverse effect; Autoimmunity; Immunotherapy; Antibody; Immune checkpoint; Cytotoxic T cell; CTLA-4; Nivolumab; T cell; Biology; Pharmacology","authors":[{"name":"Daphne Day","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01959998934634755,"gpt":0.2869797453921792,"spread":0.2673797560458316,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007471642,0.0007181471,0.00164856,0.001360543,0.0001451645,0.0007482008,0.0006396734,0.0008328957,0.003086847],"category_scores_gemma":[0.001648647,0.0002235907,0.001043447,0.001333804,0.0002534191,0.0006640479,0.0005331107,0.001254723,0.0005177026],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003757841,"about_ca_system_score_gemma":0.0007313197,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005683557,"about_ca_topic_score_gemma":0.001768856,"domain_scores_codex":[0.9995963,0.00007957825,0.0001098575,0.00005940393,0.000123116,0.00003178393],"domain_scores_gemma":[0.9990482,0.000520274,0.0002903709,0.0000158145,0.0001018521,0.00002353657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001980479,0.00006465288,0.0004667174,0.03305259,0.0004838093,0.0001637813,0.00002411891,0.0003122853,0.0007070447,0.0007701315,0.01418635,0.9495705],"study_design_scores_gemma":[0.0003143521,0.0007648051,0.005560834,0.02730029,0.003694982,0.004073403,0.00008351838,0.0004159393,0.001638546,0.002242364,0.9538482,0.00006262204],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001521199,0.9991245,0.00007249033,0.0001124707,0.00008042719,0.000004675302,0.00001908629,0.000003091064,0.0004312172],"genre_scores_gemma":[0.001657833,0.9971339,0.000205229,0.0003332463,0.0002394928,0.00000974922,0.00003808266,0.000001161743,0.0003813836],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003086847,"threshold_uncertainty_score":0.0103265,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2896685834","doi":"10.1007/s40259-018-0309-y","title":"Emerging Technologies for Delivery of Biotherapeutics and Gene Therapy Across the Blood–Brain Barrier","year":2018,"lang":"en","type":"article","venue":"BioDrugs","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"National Research Council Canada","funders":"Government of Canada","keywords":"Transcytosis; Biomanufacturing; Gene delivery; Blood–brain barrier; Transferrin receptor; Genetic enhancement; Nanocarriers; Medicine; Biology; Neuroscience; Computational biology; Immunology; Receptor; Central nervous system; Gene; Pharmacology; Drug; Biotechnology","authors":[{"name":"Danica Stanimirovic","is_ca":true},{"name":"Jagdeep K. Sandhu","is_ca":true},{"name":"Willard J. Costain","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01483342197156779,"gpt":0.2858330559010852,"spread":0.2709996339295174,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00134978,0.000809418,0.0008821709,0.00108932,0.000564573,0.002190463,0.001216725,0.001892787,0.004348732],"category_scores_gemma":[0.0009144124,0.0005030399,0.0007922967,0.0007112581,0.001232384,0.003533987,0.001388378,0.003261845,0.003606134],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001205013,"about_ca_system_score_gemma":0.001026617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005904079,"about_ca_topic_score_gemma":0.0005054888,"domain_scores_codex":[0.9988658,0.0001446347,0.00006414419,0.0001990832,0.00060552,0.0001207941],"domain_scores_gemma":[0.9995503,0.0001197897,0.0001081293,0.0000399943,0.0001277333,0.0000540737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000165033,0.0002047623,0.0005615804,0.006318219,0.0001129119,0.0007713428,0.0003164492,0.001315996,0.5345763,0.1204599,0.0174397,0.3177577],"study_design_scores_gemma":[0.0000532987,0.0005908381,0.000768599,0.0006770309,0.0001145448,0.002996789,0.0001764907,0.004480595,0.2920688,0.02475226,0.6732277,0.0000929537],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0229716,0.6123742,0.307872,0.011115,0.003256453,0.0003383775,0.0005474102,0.001334458,0.04019054],"genre_scores_gemma":[0.1441583,0.6484872,0.1680944,0.007265332,0.002071788,0.0007981043,0.0009506723,0.0002487562,0.02792556],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004348732,"threshold_uncertainty_score":0.01454794,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3094124122","doi":"10.1007/s40259-020-00451-w","title":"Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease","year":2020,"lang":"en","type":"article","venue":"BioDrugs","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":100,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ministère de l'Agriculture, des Pêcheries et de l'Alimentation; University of Calgary; Western University","funders":"","keywords":"Ustekinumab; Medicine; Interleukin 23; Ulcerative colitis; Inflammatory bowel disease; Crohn's disease; Immunology; Inflammation; Immune system; Pathogenesis; Disease; Clinical trial; Interleukin 17; Internal medicine; Tumor necrosis factor alpha; Infliximab","authors":[{"name":"Ahmed Almradi","is_ca":true},{"name":"Jurij Hanžel","is_ca":false},{"name":"Rocío Sedaño","is_ca":true},{"name":"Claire E Parker","is_ca":false},{"name":"Brian G. Feagan","is_ca":true},{"name":"Christopher Ma","is_ca":true},{"name":"Vipul Jairath","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06456502656389661,"gpt":0.3167934866840165,"spread":0.2522284601201198,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002161326,0.0007554485,0.002573711,0.0005268709,0.0004668449,0.0009494427,0.0005868954,0.001361493,0.005026446],"category_scores_gemma":[0.001199746,0.0002794421,0.001365026,0.0004895022,0.0007183491,0.0006725457,0.0003114238,0.003261533,0.00067977],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005166964,"about_ca_system_score_gemma":0.0007640546,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006066071,"about_ca_topic_score_gemma":0.001489407,"domain_scores_codex":[0.9993818,0.0003482404,0.00004527171,0.00005712722,0.00005304928,0.0001145495],"domain_scores_gemma":[0.9993389,0.000260928,0.0001047248,0.00003162459,0.00005112755,0.0002126391],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.5666901,0.01572643,0.001394039,0.00586202,0.002179773,0.0003353039,0.0002272795,0.00143804,0.02777545,0.001188873,0.005108298,0.3720744],"study_design_scores_gemma":[0.5893514,0.3718747,0.00556149,0.0008088957,0.00158383,0.0003402484,0.0001886766,0.0006012134,0.007146071,0.0007176243,0.02177791,0.0000478145],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.7521648,0.2217801,0.001825608,0.005928605,0.002186222,0.002754372,0.001169589,0.0002184075,0.0119723],"genre_scores_gemma":[0.9330254,0.05318913,0.002149499,0.002943148,0.0008797218,0.002143505,0.0009137245,0.00003415708,0.004721697],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.005026446,"threshold_uncertainty_score":0.01681519,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3212746417","doi":"10.1007/s40259-021-00507-5","title":"Anti-Drug Antibody Formation Against Biologic Agents in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis","year":2021,"lang":"en","type":"review","venue":"BioDrugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; American Gastroenterological Association","keywords":"Medicine; Inflammatory bowel disease; Drug; Meta-analysis; Antibody; Pharmacotherapy; Pharmacology; Disease; Immunology; Internal medicine","authors":[{"name":"Steven Bots","is_ca":false},{"name":"Claire E. Parker","is_ca":false},{"name":"Johannan F. Brandse","is_ca":false},{"name":"Mark Löwenberg","is_ca":false},{"name":"Brian G. Feagan","is_ca":true},{"name":"William J. Sandborn","is_ca":false},{"name":"Vipul Jairath","is_ca":true},{"name":"Geert D’Haens","is_ca":false},{"name":"Niels Vande Casteele","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04189853835288371,"gpt":0.331977762686112,"spread":0.2900792243332283,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004684047,0.001572512,0.01022045,0.002863727,0.0003004585,0.001841441,0.001318655,0.001757529,0.004229326],"category_scores_gemma":[0.01036728,0.0009449593,0.01702706,0.004595488,0.0004918813,0.001175546,0.001346602,0.001456632,0.0002846927],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001214433,"about_ca_system_score_gemma":0.001781114,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004447877,"about_ca_topic_score_gemma":0.01575125,"domain_scores_codex":[0.9970651,0.001103617,0.0009140726,0.0003927731,0.0003724149,0.0001520154],"domain_scores_gemma":[0.9934425,0.004559344,0.001401594,0.0001672766,0.0003327686,0.00009651242],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.002311401,0.00004502448,0.00618287,0.5767239,0.3789376,0.0001550462,0.000094934,0.0004100924,0.0003545169,0.0001743864,0.001274314,0.03333568],"study_design_scores_gemma":[0.001166975,0.0002932821,0.009057824,0.03884026,0.9454158,0.0001884697,0.0000796501,0.0001356069,0.000126543,0.0002479108,0.004408023,0.00003970917],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002197427,0.9971561,0.0001337805,0.00006510151,0.00005677491,0.00004798645,0.0002286759,0.000006151064,0.0001079685],"genre_scores_gemma":[0.07696828,0.9206518,0.000881135,0.000651961,0.0001298576,0.0001623134,0.0003241677,0.00001020776,0.0002203404],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01022045,"threshold_uncertainty_score":0.02477187,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1965655787","doi":"10.2165/00063030-200519010-00004","title":"Pharmacologic Approaches to the Treatment of Amyotrophic Lateral Sclerosis","year":2005,"lang":"en","type":"review","venue":"BioDrugs","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Riluzole; Amyotrophic lateral sclerosis; Glial cell line-derived neurotrophic factor; SOD1; Excitotoxicity; Neurodegeneration; Neurotrophic factors; Medicine; Oxidative stress; Neuroprotection; Pharmacology; Vascular endothelial growth factor; Glutamate receptor; Biology; Disease; Pathology; Cancer research; Internal medicine; Receptor","authors":[{"name":"Edith G. McGeer","is_ca":true},{"name":"Patrick L. McGeer","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5004309636387372,"gpt":0.4003231433586333,"spread":0.1001078202801039,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006651433,0.001369432,0.002358492,0.002997045,0.000459434,0.001007502,0.001402488,0.001390922,0.004407285],"category_scores_gemma":[0.0007914983,0.0003961089,0.0007056523,0.002456149,0.000696149,0.001222374,0.0006595493,0.002804972,0.00222809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006608967,"about_ca_system_score_gemma":0.001071725,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00221468,"about_ca_topic_score_gemma":0.005361165,"domain_scores_codex":[0.9998174,0.00003172082,0.00002889652,0.00003054707,0.00007331042,0.00001819566],"domain_scores_gemma":[0.9996796,0.0001569282,0.00005692808,0.000008825467,0.00006951109,0.00002831442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001921903,0.0002212331,0.0001002489,0.01359298,0.0001546518,0.0002935686,0.00004574225,0.0003852247,0.0021245,0.002878372,0.03089542,0.9491159],"study_design_scores_gemma":[0.0001771089,0.0002998732,0.000804375,0.005083225,0.000338552,0.001553968,0.00006493977,0.0001455784,0.0008872287,0.002028442,0.9885848,0.00003178147],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000104951,0.9982931,0.000178876,0.0001879007,0.0002169264,0.00001069991,0.00001694089,0.000009491268,0.0009811118],"genre_scores_gemma":[0.0004956381,0.9982443,0.0003046617,0.000216005,0.0001339269,0.00001111752,0.00002703179,0.000001258777,0.0005660768],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004407285,"threshold_uncertainty_score":0.01474386,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W137417466","doi":"10.2165/00063030-200519010-00005","title":"Antibody Induction Therapy in Renal Transplant Patients Receiving Calcineurin-Inhibitor Immunosuppressive Regimens","year":2005,"lang":"en","type":"review","venue":"BioDrugs","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Health Sciences Centre","funders":"","keywords":"Medicine; Basiliximab; Daclizumab; Thymoglobulin; Calcineurin; Immunology; Internal medicine; Transplantation; Gastroenterology; Tacrolimus","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04379392079459723,"gpt":0.3572671704822917,"spread":0.3134732496876945,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000679829,0.0004067334,0.002138302,0.0009687227,0.0001553671,0.0004578398,0.0006726377,0.0005592044,0.001721748],"category_scores_gemma":[0.001311612,0.0001526357,0.0007765589,0.001128895,0.0001868093,0.0004175661,0.0002300281,0.000835505,0.0002774569],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003632076,"about_ca_system_score_gemma":0.000775551,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000930946,"about_ca_topic_score_gemma":0.002522653,"domain_scores_codex":[0.999736,0.00007525473,0.00006529359,0.00003067057,0.00007539201,0.00001735519],"domain_scores_gemma":[0.9993103,0.0004398806,0.0001746435,0.000007049383,0.00004914802,0.00001900858],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0004727507,0.0001351576,0.001122141,0.02663421,0.0005953075,0.0001908826,0.00003559355,0.0001592906,0.0007679659,0.0003534486,0.005248089,0.9642852],"study_design_scores_gemma":[0.00287547,0.004076436,0.06546751,0.09289498,0.01833106,0.01237394,0.0004269965,0.0009212319,0.005255967,0.002726123,0.7945067,0.0001436205],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0005731601,0.9989898,0.00004693906,0.00006974702,0.0000390294,0.000004056285,0.000008447221,0.000001897867,0.0002668668],"genre_scores_gemma":[0.005365293,0.9940127,0.0002009974,0.0001484176,0.00009553509,0.00001132226,0.00002910623,6.116404e-7,0.0001359098],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002138302,"threshold_uncertainty_score":0.005759776,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2052842550","doi":"10.2165/00063030-200115120-00005","title":"Current and Future Applications of Immunological Attenuation via Pegylation of Cells and Tissue","year":2001,"lang":"en","type":"review","venue":"BioDrugs","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; University of British Columbia Hospital","funders":"National Heart, Lung, and Blood Institute; National Institutes of Health","keywords":"Transplantation; PEGylation; Immune system; Immunology; Immunosuppression; Immunogenicity; Immunologic Tolerance; Antigenicity; Alloimmunity; Antibody; Medicine; In vivo; Immune tolerance; Cancer research; Biology; Internal medicine","authors":[{"name":"Audrey M. Chen","is_ca":false},{"name":"Mark D. Scott","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0297655885367215,"gpt":0.3219776703747264,"spread":0.2922120818380048,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008282859,0.0008616151,0.0009035221,0.0007499304,0.0002413598,0.0008015255,0.000850214,0.001205757,0.003038375],"category_scores_gemma":[0.0003224193,0.0002345534,0.0004037807,0.000828794,0.0005628518,0.001803192,0.0003529014,0.00118111,0.001567742],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004628841,"about_ca_system_score_gemma":0.0005129314,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004720807,"about_ca_topic_score_gemma":0.0008659447,"domain_scores_codex":[0.9998963,0.00001560353,0.00001289683,0.00002485167,0.00003400609,0.00001637432],"domain_scores_gemma":[0.9998492,0.00007565676,0.00002258906,0.000008910851,0.00002868366,0.00001483358],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002342963,0.0002356831,0.0002235859,0.00424351,0.00003898695,0.0003714926,0.00006791837,0.0008128923,0.03941817,0.006400703,0.006099342,0.9418533],"study_design_scores_gemma":[0.00008506676,0.0006068554,0.001177018,0.001007094,0.0001387355,0.003179331,0.0001207278,0.0006248199,0.02915859,0.00488332,0.9589825,0.00003596129],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00195699,0.9882787,0.003976816,0.0005427467,0.0003995221,0.00001661722,0.00001823159,0.00003198773,0.004778347],"genre_scores_gemma":[0.006324074,0.9854414,0.002937239,0.0005342187,0.0002733239,0.0000273488,0.00006185724,0.000006927361,0.004393509],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003038375,"threshold_uncertainty_score":0.01016438,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W183087027","doi":"10.2165/00063030-200418050-00004","title":"Islet Transplantation in Patients with Diabetes Mellitus","year":2004,"lang":"en","type":"review","venue":"BioDrugs","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Immunosuppression; Transplantation; Azathioprine; Diabetes mellitus; Tacrolimus; Sirolimus; Type 1 diabetes; Insulin; Islet; Everolimus; Organ transplantation; Immunology; Intensive care medicine; Internal medicine; Endocrinology; Disease","authors":[{"name":"Sulaiman Nanji","is_ca":true},{"name":"A. M. James Shapiro","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01529438150529137,"gpt":0.2579263903664687,"spread":0.2426320088611774,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065065,0.0008335913,0.00222033,0.001768479,0.0001949296,0.0008430652,0.0005693424,0.000877065,0.002924075],"category_scores_gemma":[0.0009920171,0.0001868567,0.0006807026,0.001957653,0.0004133015,0.0009433608,0.0005589004,0.001542474,0.0008577854],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003221901,"about_ca_system_score_gemma":0.000642402,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005843686,"about_ca_topic_score_gemma":0.001632059,"domain_scores_codex":[0.9998245,0.00004118317,0.00003760413,0.00002924605,0.00005224229,0.00001527811],"domain_scores_gemma":[0.9995517,0.0002734317,0.0000847946,0.00001168152,0.00004797813,0.00003031055],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002470805,0.00007493929,0.000400089,0.01080114,0.0001444378,0.0004248621,0.00002503009,0.0001540273,0.0005801691,0.0006373811,0.01309564,0.9734152],"study_design_scores_gemma":[0.0004239205,0.0006409472,0.005527208,0.01533176,0.001856783,0.00973291,0.000177899,0.0002236119,0.00118031,0.001852757,0.9630002,0.00005165837],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001574328,0.9989017,0.00008226886,0.0001395595,0.0001708675,0.0000022861,0.000006104395,0.000003594761,0.0005361506],"genre_scores_gemma":[0.00131537,0.9976126,0.0001359902,0.0003124028,0.0002669145,0.000004805328,0.00001572733,0.000001117389,0.0003351783],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002924075,"threshold_uncertainty_score":0.009782016,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2131592861","doi":"10.1007/s40259-015-0130-9","title":"Next-Generation Covalent Irreversible Kinase Inhibitors in NSCLC: Focus on Afatinib","year":2015,"lang":"en","type":"review","venue":"BioDrugs","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Royal Victoria Hospital","funders":"Boehringer Ingelheim","keywords":"Afatinib; Erlotinib; Gefitinib; Epidermal growth factor receptor; Lung cancer; Medicine; Oncology; Cetuximab; Internal medicine; EGFR inhibitors; Cancer research; Tyrosine kinase; Pharmacology; Cancer; Receptor","authors":[{"name":"Vera Hirsh","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1326961338418439,"gpt":0.3950047831603708,"spread":0.2623086493185269,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004334257,0.0004586724,0.0006337822,0.0006099479,0.0001243317,0.0005062963,0.000455528,0.0007161631,0.001024873],"category_scores_gemma":[0.0003277521,0.0001734895,0.0004444498,0.000617607,0.0002409181,0.001184453,0.0003567997,0.001363789,0.0006651966],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004492086,"about_ca_system_score_gemma":0.0003365645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003430118,"about_ca_topic_score_gemma":0.0009490711,"domain_scores_codex":[0.9998435,0.00003256673,0.00002115505,0.00003537216,0.00004313095,0.00002427544],"domain_scores_gemma":[0.9998949,0.00004392177,0.00001863985,0.0000032832,0.00002505085,0.00001430379],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002094001,0.0001774478,0.0004720154,0.009799383,0.0001425626,0.0008242025,0.000136131,0.001401152,0.0191651,0.009133227,0.03273483,0.9258045],"study_design_scores_gemma":[0.00007010647,0.0008185208,0.0011748,0.0009190768,0.0001668851,0.00498335,0.00006183719,0.0007723478,0.00528434,0.00223862,0.9834803,0.00002996305],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001649482,0.9935921,0.001192647,0.000907453,0.0004466785,0.00001630594,0.00002747719,0.00002258672,0.002145197],"genre_scores_gemma":[0.013482,0.9805705,0.001283919,0.001247476,0.000728535,0.00002411784,0.00007872494,0.000008856733,0.002575847],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001024873,"threshold_uncertainty_score":0.003428519,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1778153929","doi":"10.1007/s40259-015-0144-3","title":"Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast","year":2015,"lang":"en","type":"review","venue":"BioDrugs","topic":"Phosphodiesterase function and regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":68,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; SKiN Health","funders":"","keywords":"Apremilast; Psoriasis; Medicine; Proinflammatory cytokine; Pharmacology; Tumor necrosis factor alpha; Immunology; Tofacitinib; Phosphodiesterase; Inflammation; Psoriatic arthritis; Rheumatoid arthritis; Chemistry","authors":[{"name":"Melinda Gooderham","is_ca":true},{"name":"Kim Papp","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0367836431140947,"gpt":0.3169684356943395,"spread":0.2801847925802448,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008518793,0.0008513887,0.0009809252,0.0009099382,0.0002369177,0.0008706644,0.000606529,0.001185751,0.004424988],"category_scores_gemma":[0.000480673,0.0002558339,0.0005646949,0.0007068504,0.0004024175,0.001242854,0.0005553404,0.003948933,0.002502144],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004278476,"about_ca_system_score_gemma":0.0005212422,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004427793,"about_ca_topic_score_gemma":0.001685064,"domain_scores_codex":[0.9997579,0.00005524136,0.00002224511,0.00006010592,0.00006920524,0.0000351612],"domain_scores_gemma":[0.9995717,0.000125954,0.00006043543,0.00001102813,0.0001404188,0.0000904596],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009316137,0.0008926425,0.0004617671,0.005823447,0.0001278773,0.0009486573,0.0001326488,0.0004301,0.02366221,0.005999874,0.06175725,0.898832],"study_design_scores_gemma":[0.0008242739,0.003341952,0.002404387,0.001777269,0.0001951315,0.00386914,0.00008346739,0.0006434995,0.00471328,0.002661332,0.9794289,0.00005738151],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004769811,0.9730113,0.002714081,0.009276625,0.001531904,0.0001254641,0.000142779,0.0001126491,0.008315267],"genre_scores_gemma":[0.02406421,0.9422787,0.005365931,0.01227377,0.00372621,0.000164239,0.000391031,0.00006758294,0.01166834],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004424988,"threshold_uncertainty_score":0.01480305,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2015187915","doi":"10.2165/00063030-200822040-00002","title":"Strategies Toward the Improved Oral Delivery of Insulin Nanoparticles via Gastrointestinal Uptake and Translocation","year":2008,"lang":"en","type":"review","venue":"BioDrugs","topic":"Advanced Drug Delivery Systems","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":67,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Insulin; Glycemic; Gastrointestinal tract; Nanoparticle; Diabetes mellitus; Nanotechnology; Pharmacology; Medicine; Chemistry; Materials science; Internal medicine; Endocrinology","authors":[{"name":"Camile B. Woitiski","is_ca":false},{"name":"Rui A. Carvalho","is_ca":false},{"name":"António J. Ribeiro","is_ca":false},{"name":"Ronald J. Neufeld","is_ca":true},{"name":"Francisco Veiga","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1589632605650296,"gpt":0.4157631336086455,"spread":0.2567998730436158,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004452577,0.001003589,0.001300347,0.001042753,0.0002040944,0.0008675411,0.0008170962,0.001038902,0.001310156],"category_scores_gemma":[0.0001856616,0.0003477875,0.0004746359,0.0008659583,0.0005061766,0.001107214,0.000645596,0.001565204,0.00135857],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006817069,"about_ca_system_score_gemma":0.0004329634,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007260182,"about_ca_topic_score_gemma":0.0009816417,"domain_scores_codex":[0.9998909,0.00001555169,0.00000945569,0.00002454824,0.00004201305,0.00001762389],"domain_scores_gemma":[0.9999357,0.00002133624,0.0000149795,0.000003944543,0.0000179771,0.000005965933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001385307,0.0003059311,0.0001263914,0.008024455,0.00006681608,0.0005167621,0.0001142345,0.001315899,0.1295131,0.009964131,0.006193011,0.8437208],"study_design_scores_gemma":[0.0001016861,0.0006903361,0.0008970255,0.0011235,0.0001692161,0.002887851,0.000100146,0.001797474,0.1215316,0.004250431,0.8663791,0.00007160989],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004744276,0.9808414,0.009544963,0.0005456135,0.0002922053,0.00004498123,0.00003682661,0.00006882945,0.003880825],"genre_scores_gemma":[0.01335468,0.9738432,0.006870451,0.0003707887,0.0001425109,0.00006191965,0.0000821662,0.00001246557,0.005261956],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001310156,"threshold_uncertainty_score":0.004946172,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402620082","doi":"10.1007/s40259-024-00677-y","title":"Chikungunya Virus Vaccines: A Review of IXCHIQ and PXVX0317 from Pre-Clinical Evaluation to Licensure","year":2024,"lang":"en","type":"review","venue":"BioDrugs","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases; National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences","keywords":"Chikungunya; Medicine; Clinical trial; European union; Virology; Alphavirus; Licensure; Virus; Internal medicine; Business","authors":[{"name":"Whitney C. Weber","is_ca":false},{"name":"Daniel N. Streblow","is_ca":false},{"name":"Lark L. Coffey","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0731524147698617,"gpt":0.4688754399647942,"spread":0.3957230251949325,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001584908,0.0007003407,0.001208838,0.001850618,0.0002405965,0.001072795,0.0008159959,0.00106768,0.003563494],"category_scores_gemma":[0.002183641,0.0003533982,0.00123939,0.001385026,0.0003447386,0.001213875,0.0004972822,0.001486053,0.001195617],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005513481,"about_ca_system_score_gemma":0.001471321,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001084905,"about_ca_topic_score_gemma":0.001796946,"domain_scores_codex":[0.9995011,0.0001269515,0.0001236067,0.00005816542,0.0001489011,0.00004131928],"domain_scores_gemma":[0.9989594,0.0005622206,0.0001776559,0.0000214646,0.0002323727,0.00004685806],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003204685,0.0001385099,0.000270709,0.05528148,0.000266625,0.0003120686,0.0001838461,0.0004185187,0.003027643,0.002480383,0.02852948,0.9087703],"study_design_scores_gemma":[0.00007958649,0.0005965937,0.001128133,0.01781745,0.0005587599,0.0009656093,0.00007013931,0.0001014133,0.001045373,0.0008764368,0.9767328,0.0000276762],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003341783,0.9979298,0.0001354651,0.0003774991,0.0001654101,0.0000249271,0.00005313669,0.000007426865,0.0009720768],"genre_scores_gemma":[0.001373463,0.9971237,0.0002985034,0.000482122,0.0001352455,0.00004211458,0.00008212586,0.000003239136,0.0004595402],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003563494,"threshold_uncertainty_score":0.01192105,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2047330433","doi":"10.2165/00063030-200923020-00002","title":"Current Status and Challenges Associated with Targeting mTOR for Cancer Therapy","year":2009,"lang":"en","type":"review","venue":"BioDrugs","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Jewish General Hospital; McGill University; McGill University Health Centre","funders":"Howard Hughes Medical Institute","keywords":"PI3K/AKT/mTOR pathway; Sirolimus; Protein kinase B; Cancer; Cancer research; RPTOR; Signal transduction; Pharmacology; Biology; Medicine; Internal medicine; Cell biology","authors":[{"name":"Ryan J.O. Dowling","is_ca":true},{"name":"Michaël Pollak","is_ca":true},{"name":"Nahum Sonenberg","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07859009767915429,"gpt":0.3535119843236535,"spread":0.2749218866444992,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001584798,0.0009741422,0.002023988,0.001446908,0.0004534565,0.00160065,0.001378917,0.001986697,0.004826501],"category_scores_gemma":[0.001250101,0.0004798474,0.0005816648,0.001725396,0.0009582699,0.002420516,0.0008693256,0.002941176,0.002957727],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009268955,"about_ca_system_score_gemma":0.001270249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00117831,"about_ca_topic_score_gemma":0.003039408,"domain_scores_codex":[0.9997397,0.00004813377,0.00003314451,0.000046807,0.0001003365,0.00003182638],"domain_scores_gemma":[0.9995199,0.0002787938,0.00004754118,0.00001463128,0.0001033872,0.00003568318],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002003068,0.0001427214,0.0001537837,0.007521747,0.00007104837,0.000290652,0.00004502034,0.0008146835,0.003790672,0.007571067,0.04290213,0.9364963],"study_design_scores_gemma":[0.00005726479,0.0001590663,0.000328932,0.001347355,0.0001150334,0.001086512,0.00005537087,0.0003478176,0.001415062,0.003193328,0.9918732,0.0000210477],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001586148,0.9969542,0.0004425022,0.0007544792,0.0003455066,0.000006032711,0.00001509707,0.00001365566,0.001309948],"genre_scores_gemma":[0.0009766784,0.9963391,0.0007173722,0.0004613789,0.0004026996,0.00001487808,0.00002925805,0.000003909147,0.001054815],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004826501,"threshold_uncertainty_score":0.01614618,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2089502375","doi":"10.1007/s40259-012-0003-4","title":"Targeting Focal Adhesion Kinase in Fibrotic Diseases","year":2012,"lang":"en","type":"review","venue":"BioDrugs","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Fibrosis; Extracellular matrix; Focal adhesion; Medicine; Scleroderma (fungus); Pulmonary fibrosis; Idiopathic pulmonary fibrosis; Cancer research; Signal transduction; Pathology; Immunology; Biology; Lung; Cell biology; Internal medicine","authors":[{"name":"David Lagares","is_ca":false},{"name":"Mohit Kapoor","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03822410845400634,"gpt":0.3191907090961403,"spread":0.280966600642134,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005519121,0.00117012,0.001749333,0.00199733,0.0002018229,0.0008136771,0.0006742104,0.001204138,0.003200379],"category_scores_gemma":[0.0005742779,0.0003994617,0.0005290103,0.001424666,0.0004218247,0.001275264,0.0006147956,0.001876573,0.00170312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004177889,"about_ca_system_score_gemma":0.0006237371,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000719414,"about_ca_topic_score_gemma":0.001649774,"domain_scores_codex":[0.9998757,0.00001839672,0.00002038125,0.00002053654,0.00004709126,0.00001790679],"domain_scores_gemma":[0.9998217,0.00008306815,0.00003474678,0.000005366703,0.00003708807,0.00001801799],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000178713,0.0001558532,0.00009733169,0.01518318,0.0001123149,0.000230261,0.00004402888,0.0006306579,0.00704531,0.002240475,0.02423882,0.949843],"study_design_scores_gemma":[0.0001435182,0.0003562249,0.0008265689,0.003381181,0.0003883259,0.001701918,0.00004949545,0.0004317521,0.002888441,0.00154967,0.9882467,0.00003616571],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000291483,0.9974795,0.0003802351,0.0001996457,0.0002057336,0.00001335086,0.0000280766,0.00001319996,0.001388833],"genre_scores_gemma":[0.001541086,0.9961649,0.000444189,0.0002669243,0.0001564487,0.00001856242,0.0000536671,0.000002532731,0.001351745],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003200379,"threshold_uncertainty_score":0.01070637,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2923414225","doi":"10.1007/s40259-019-00347-4","title":"PARP Inhibitors and the Evolving Landscape of Ovarian Cancer Management: A Review","year":2019,"lang":"en","type":"review","venue":"BioDrugs","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Ovarian cancer; Medicine; Cancer; Oncology; Pharmacotherapy; Internal medicine","authors":[{"name":"Sarah Cook","is_ca":false},{"name":"Anna V. Tinker","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04552099282661187,"gpt":0.3574579287860135,"spread":0.3119369359594016,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007555384,0.0007279929,0.001613971,0.002205021,0.0002485496,0.001251243,0.0009489486,0.001283828,0.004116502],"category_scores_gemma":[0.001291579,0.0002972089,0.0006773643,0.002183901,0.0003873646,0.00133773,0.0006805339,0.00194381,0.00111265],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000623105,"about_ca_system_score_gemma":0.001256138,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001132259,"about_ca_topic_score_gemma":0.003133504,"domain_scores_codex":[0.9998072,0.00004020829,0.00003515448,0.00003770683,0.00006219978,0.0000175507],"domain_scores_gemma":[0.9993522,0.0003947662,0.0001040445,0.000009864425,0.00009980966,0.00003932517],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001453923,0.00007419826,0.0001878203,0.03720618,0.0001630331,0.0001801862,0.00004331794,0.0004538967,0.0009052202,0.002146888,0.03815861,0.9203354],"study_design_scores_gemma":[0.00006407522,0.0002356062,0.0008968583,0.01474591,0.0005323395,0.001160122,0.00007723273,0.0002041214,0.0003081965,0.001740909,0.9800047,0.00002993135],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004631226,0.9992742,0.00004439388,0.0002192144,0.00010647,0.000002990245,0.00001559172,0.000003583705,0.0002872898],"genre_scores_gemma":[0.0003044223,0.9990715,0.00008446668,0.0002278444,0.0001318913,0.000003600189,0.00001816658,6.021462e-7,0.0001574875],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004116502,"threshold_uncertainty_score":0.01377106,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2067292160","doi":"10.2165/11586210-000000000-00000","title":"Autoimmune Hepatitis Induced by Infliximab in a Patient with Crohnʼs Disease with no Relapse After Switching to Adalimumab","year":2010,"lang":"en","type":"article","venue":"BioDrugs","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Alberta Innovates - Health Solutions","keywords":"Infliximab; Adalimumab; Medicine; Autoimmune hepatitis; Crohn's disease; Internal medicine; Disease; Gastroenterology; Inflammatory bowel disease; Tumor necrosis factor alpha; Hepatitis; Immunology","authors":[{"name":"Marília Cravo","is_ca":false},{"name":"Rosa Silva","is_ca":false},{"name":"Miguel Ángel Tapia‐Serrano","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.004201924402870781,"gpt":0.2110650540486236,"spread":0.2068631296457528,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003929971,0.001286767,0.001212486,0.001774585,0.0021393,0.001174517,0.001218152,0.00466136,0.003175044],"category_scores_gemma":[0.002838189,0.0007050665,0.002150501,0.0009060972,0.001091994,0.001040075,0.0007313427,0.003728306,0.0009826889],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001241097,"about_ca_system_score_gemma":0.0007346992,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003440884,"about_ca_topic_score_gemma":0.003220471,"domain_scores_codex":[0.9994457,0.00008358265,0.00007639132,0.0001188714,0.00005771673,0.0002177046],"domain_scores_gemma":[0.9984084,0.0005155272,0.000205516,0.000156049,0.0000985565,0.0006159494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.0004954581,0.0001773728,0.0196681,0.00002848623,0.00003086742,0.9764854,0.0001850216,0.00006011752,0.0008551185,0.00007473346,0.0002683684,0.001670991],"study_design_scores_gemma":[0.000193343,0.001010188,0.04823833,0.00002950276,0.0001214175,0.9479157,0.00025337,0.0005550026,0.000736411,0.000144255,0.0007658762,0.00003655049],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9816443,0.001615233,0.0005793648,0.003762553,0.0003857705,0.00008691827,0.0001435988,0.0001046882,0.0116775],"genre_scores_gemma":[0.9966066,0.0003764806,0.0002097502,0.001197812,0.0004989745,0.00001001551,0.0001002188,0.00001713975,0.0009830459],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00466136,"threshold_uncertainty_score":0.01062161,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W34856137","doi":"10.2165/0063030-200822060-00003","title":"Embryonic Stem Cell Transplantation","year":2008,"lang":"en","type":"review","venue":"BioDrugs","topic":"Pluripotent Stem Cells Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":45,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Transplantation; Stem cell; Medicine; Myocyte; Progenitor cell; Embryonic stem cell; Cell therapy; Angiogenesis; Stem-cell therapy; Internal medicine; Pathology; Biology; Cell biology","authors":[{"name":"Feixiong Zhang","is_ca":true},{"name":"Kishore B.S. Pasumarthi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03194788123583159,"gpt":0.2997860719150581,"spread":0.2678381906792265,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006651674,0.001120085,0.001173573,0.001331407,0.0002799306,0.0007831756,0.0009510955,0.001125771,0.006580298],"category_scores_gemma":[0.0003658949,0.0002592845,0.0003618489,0.001039513,0.0008525045,0.000853778,0.0008508879,0.001843852,0.004274873],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005809828,"about_ca_system_score_gemma":0.0006087254,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005785859,"about_ca_topic_score_gemma":0.001426405,"domain_scores_codex":[0.9998447,0.00002172489,0.00001340079,0.00003419409,0.00006974856,0.00001625227],"domain_scores_gemma":[0.9998921,0.00004259461,0.00001279697,0.00001168,0.00002569963,0.00001510804],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00006172364,0.00007341058,0.0001023708,0.002465809,0.00002734727,0.0004248433,0.00002445355,0.0003035729,0.00863234,0.01106805,0.04580544,0.9310108],"study_design_scores_gemma":[0.00001725197,0.00002871605,0.0002223902,0.0004585575,0.00002647054,0.001177011,0.0000145475,0.00007331216,0.003447971,0.002601598,0.9919232,0.00000898585],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0009609431,0.9527617,0.009363221,0.001243631,0.003966558,0.00006868062,0.0001304729,0.000170885,0.03133397],"genre_scores_gemma":[0.005096063,0.9479845,0.005426604,0.001993557,0.001125635,0.00009138682,0.0003232873,0.00003352546,0.03792542],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006580298,"threshold_uncertainty_score":0.02201325,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2954341438","doi":"10.1007/s40259-019-00361-6","title":"Bimekizumab: The First Dual Inhibitor of Interleukin (IL)-17A and IL-17F for the Treatment of Psoriatic Disease and Ankylosing Spondylitis","year":2019,"lang":"en","type":"review","venue":"BioDrugs","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":43,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Psoriatic arthritis; Medicine; Psoriasis; Ankylosing spondylitis; Tolerability; Interleukin 17; Immunology; Disease; Interleukin 23; Interleukin 22; Clinical trial; Psoriasis Area and Severity Index; Spondylitis; Interleukin; Dermatology; Internal medicine; Cytokine; Adverse effect","authors":[{"name":"Joel Reis","is_ca":false},{"name":"Ronald Vender","is_ca":true},{"name":"Tiago Torres","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04080093537706545,"gpt":0.2807410066708714,"spread":0.239940071293806,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005571783,0.0008218936,0.001226648,0.0012931,0.0001900582,0.0008821163,0.0007745484,0.00107173,0.002549934],"category_scores_gemma":[0.000522015,0.0002159008,0.0004246067,0.000968099,0.000372294,0.0008932903,0.0005427734,0.002630688,0.001869999],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005681016,"about_ca_system_score_gemma":0.0008606476,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001011616,"about_ca_topic_score_gemma":0.00243699,"domain_scores_codex":[0.9998436,0.00002356292,0.00001978532,0.00002472785,0.00006389619,0.00002443732],"domain_scores_gemma":[0.9998165,0.0000700831,0.00003418067,0.000004684746,0.0000465841,0.00002797594],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001799921,0.00008026869,0.00007837652,0.005475052,0.00007696605,0.0001374543,0.00002428454,0.0002697622,0.001860116,0.002655552,0.04095797,0.9482042],"study_design_scores_gemma":[0.0001100904,0.0001768151,0.0004222278,0.001411411,0.0001115798,0.0009207886,0.00001957462,0.0001116358,0.0006845193,0.001075826,0.9949399,0.00001567425],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001494934,0.9980856,0.000166272,0.0003253241,0.000434572,0.000006122282,0.00002552469,0.00001043665,0.0007967675],"genre_scores_gemma":[0.001250061,0.9958737,0.0002766041,0.0006359604,0.0003117656,0.000009449,0.00006275728,0.000002707377,0.001576881],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002549934,"threshold_uncertainty_score":0.008530438,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1976055108","doi":"10.2165/00063030-200317040-00006","title":"Meta-Analysis of Basiliximab for Immunoprophylaxis in Renal Transplantation","year":2003,"lang":"en","type":"review","venue":"BioDrugs","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Simon Fraser University; University of British Columbia","funders":"","keywords":"Basiliximab; Medicine; Transplantation; Internal medicine; Azathioprine; Placebo; Kidney transplantation; Gastroenterology; Surgery; Pathology","authors":[{"name":"Paul Keown","is_ca":true},{"name":"Robert Balshaw","is_ca":true},{"name":"Shideh Khorasheh","is_ca":true},{"name":"Mei Chong","is_ca":true},{"name":"Carlo A. Marra","is_ca":true},{"name":"Zoltán Kaló","is_ca":false},{"name":"Alex P. Korn","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1943935681286605,"gpt":0.3986355242844454,"spread":0.2042419561557849,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01175635,0.002694833,0.01504317,0.001981598,0.0004299366,0.001518655,0.001610325,0.001591287,0.002775439],"category_scores_gemma":[0.02031938,0.001193898,0.0264883,0.003023656,0.0004872729,0.0008944047,0.0009973538,0.001851276,0.0002102334],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001813222,"about_ca_system_score_gemma":0.002091949,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0052229,"about_ca_topic_score_gemma":0.01028919,"domain_scores_codex":[0.9918759,0.005249182,0.001326685,0.0007027548,0.0006254772,0.0002200211],"domain_scores_gemma":[0.9872921,0.009734445,0.001847521,0.0004272989,0.0005089683,0.0001897707],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.01510432,0.0000489732,0.004204106,0.0660398,0.8969124,0.0001112911,0.00003988261,0.0008261041,0.0002816491,0.00009515438,0.0006027228,0.01573369],"study_design_scores_gemma":[0.002856216,0.0004884712,0.002793551,0.001796052,0.9905945,0.00007141518,0.00001488437,0.000197289,0.000138206,0.0001195151,0.0009163427,0.00001355767],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01755952,0.9797642,0.001189974,0.0002541678,0.0003701434,0.0001350002,0.0003974661,0.00004279565,0.0002866838],"genre_scores_gemma":[0.500989,0.492305,0.003452068,0.001050817,0.0005756309,0.0004350594,0.0005850469,0.00004487774,0.0005625405],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01504317,"threshold_uncertainty_score":0.06217426,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2061784015","doi":"10.2165/11539070-000000000-00000","title":"Systemic and Mucosal Delivery of Drugs within Polymeric Microparticles Produced by Spray Drying","year":2010,"lang":"en","type":"review","venue":"BioDrugs","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Spray drying; Drug delivery; Controlled release; Drug; Dosage form; Chitosan; Pharmacology; Nanotechnology; Materials science; Chemistry; Medicine; Chromatography; Organic chemistry","authors":[{"name":"Kristen Bowey","is_ca":true},{"name":"Ronald J. Neufeld","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02081753502042624,"gpt":0.2911116718339339,"spread":0.2702941368135077,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002816106,0.0007262249,0.0009291074,0.001126345,0.0001332894,0.0003952655,0.0004290224,0.0005740052,0.0008785697],"category_scores_gemma":[0.0001381803,0.0002659865,0.0003351593,0.0008441769,0.0002554349,0.000616809,0.0002728725,0.0006297895,0.0008479168],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003015622,"about_ca_system_score_gemma":0.0002245679,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000518577,"about_ca_topic_score_gemma":0.0007866896,"domain_scores_codex":[0.9999127,0.000008148601,0.000008913806,0.00002059394,0.00003807232,0.00001150862],"domain_scores_gemma":[0.9999518,0.00001762438,0.0000129969,0.000002641377,0.00001144983,0.00000351119],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001406485,0.0001512422,0.0001138721,0.007773002,0.00005976358,0.00039458,0.00006384799,0.0005673835,0.2055595,0.00162226,0.003308829,0.7802451],"study_design_scores_gemma":[0.00006189488,0.0009468147,0.002720941,0.001151369,0.0002694234,0.005178505,0.00007727628,0.001080038,0.2569349,0.000956571,0.7305489,0.00007345714],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006617314,0.9874724,0.002619073,0.00008539831,0.0001285549,0.00002635579,0.00003006394,0.00003952626,0.002981312],"genre_scores_gemma":[0.02131378,0.9672999,0.003161931,0.0001459842,0.0001377866,0.00003302979,0.00009133456,0.00001214872,0.00780418],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001126345,"threshold_uncertainty_score":0.002939105,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2613074462","doi":"10.1007/s40259-017-0219-4","title":"Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents","year":2017,"lang":"en","type":"article","venue":"BioDrugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Concordance; Immunoassay; Cross-reactivity; Infliximab; Antibody; Rheumatoid arthritis; Internal medicine; Cross reactions; Immunology; Tumor necrosis factor alpha","authors":[{"name":"Walter Reinisch","is_ca":true},{"name":"Jørgen Jahnsen","is_ca":false},{"name":"Stefan Schreiber","is_ca":false},{"name":"Silvio Danese","is_ca":false},{"name":"Julián Panés","is_ca":false},{"name":"Alejandro Balsa","is_ca":false},{"name":"Won Park","is_ca":false},{"name":"Ji‐Soo Kim","is_ca":false},{"name":"Jee Un Lee","is_ca":false},{"name":"Dae‐Hyun Yoo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09935088227926661,"gpt":0.395455338091884,"spread":0.2961044558126174,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00352714,0.0006121531,0.0004156209,0.001302794,0.0001994572,0.000464123,0.0004501014,0.0007557005,0.0004964132],"category_scores_gemma":[0.004255688,0.0002873295,0.0005313056,0.0007922084,0.0003722331,0.0002330505,0.0003511067,0.000574583,0.0002054296],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003420723,"about_ca_system_score_gemma":0.0001565971,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005432185,"about_ca_topic_score_gemma":0.0004235762,"domain_scores_codex":[0.9957954,0.001521582,0.0003688112,0.0005637211,0.001569599,0.0001810018],"domain_scores_gemma":[0.9966479,0.001105989,0.001207941,0.0002956359,0.0006149908,0.0001275622],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.005110908,0.0007027094,0.3128136,0.000488092,0.0006047421,0.0006927151,0.0007040452,0.0008658579,0.6508279,0.0001955529,0.0002075681,0.02678636],"study_design_scores_gemma":[0.0002253661,0.008570447,0.5653071,0.00006970631,0.0004248797,0.01136438,0.0002518904,0.01108534,0.4003767,0.00009146483,0.002181254,0.00005138899],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9922791,0.00136754,0.005371148,0.00001854752,0.00001809564,0.00006984218,0.00009142574,0.00003854077,0.0007458651],"genre_scores_gemma":[0.9943237,0.000247445,0.004814262,0.00004503343,0.00001054032,0.0000543804,0.0002708642,0.000005668292,0.0002280044],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00352714,"threshold_uncertainty_score":0.01865351,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2930500067","doi":"10.1007/s40259-019-00346-5","title":"Different Policy Measures and Practices between Swedish Counties Influence Market Dynamics: Part 2—Biosimilar and Originator Etanercept in the Outpatient Setting","year":2019,"lang":"en","type":"article","venue":"BioDrugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Stockholms Läns Landsting","keywords":"Biosimilar; Market share; Medical prescription; Etanercept; Pharmacy; Prior authorization; Business; Reimbursement; Medicine; Quarter (Canadian coin); Marketing; Family medicine; Public economics; Health care; Economics; Economic growth; Nursing","authors":[{"name":"Evelien Moorkens","is_ca":false},{"name":"Steven Simoens","is_ca":false},{"name":"Per Troein","is_ca":false},{"name":"Paul Declerck","is_ca":false},{"name":"Arnold G. Vulto","is_ca":false},{"name":"Isabelle Huys","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01744734384482944,"gpt":0.298849918284737,"spread":0.2814025744399076,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007677327,0.0001423858,0.0003030855,0.002076198,0.001147545,0.004288399,0.0007443783,0.0007344476,0.002322029],"category_scores_gemma":[0.02513544,0.0002322504,0.0004560998,0.002652081,0.001637448,0.001345809,0.002110178,0.0006766716,0.0002069579],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.007078258,"about_ca_system_score_gemma":0.009239065,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04198865,"about_ca_topic_score_gemma":0.04106987,"domain_scores_codex":[0.9910724,0.004737488,0.0007742405,0.0009073667,0.001295503,0.001213146],"domain_scores_gemma":[0.9632719,0.02098238,0.01059092,0.0006923043,0.002871719,0.001590762],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0007325817,0.0004055508,0.8967289,0.001044009,0.0002392848,0.0008626717,0.03924072,0.001370769,0.00112465,0.005297362,0.003317567,0.04963598],"study_design_scores_gemma":[0.00003935151,0.0002648816,0.9367136,0.0006209656,0.0001274027,0.0002553021,0.04887569,0.0004870288,0.0005988786,0.0007786952,0.01120059,0.00003761793],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935687,0.001504182,0.0003500504,0.001449084,0.0000193151,0.00003172475,0.0002064543,0.00000963124,0.002860902],"genre_scores_gemma":[0.9984943,0.0005349272,0.0003823606,0.0001453587,0.00001011707,0.00003490453,0.0001160299,0.000006014022,0.0002760314],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04198865,"threshold_uncertainty_score":0.08348846,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4388902238","doi":"10.1007/s40259-023-00630-5","title":"Efficacy and Safety of Candidate Biosimilar CT-P43 Versus Originator Ustekinumab in Moderate to Severe Plaque Psoriasis: 28-Week Results of a Randomised, Active-Controlled, Double-Blind, Phase III Study","year":2023,"lang":"en","type":"article","venue":"BioDrugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; University of Toronto","funders":"Celltrion","keywords":"Ustekinumab; Medicine; Psoriasis Area and Severity Index; Clinical endpoint; Biosimilar; Dosing; Adverse effect; Randomized controlled trial; Psoriasis; Tolerability; Internal medicine; Dermatology; Adalimumab","authors":[{"name":"Kim Papp","is_ca":true},{"name":"Mark Lebwohl","is_ca":false},{"name":"Diamant Thaçi","is_ca":false},{"name":"Janusz Jaworski","is_ca":false},{"name":"Bartłomiej Kwiek","is_ca":false},{"name":"Jakub Trefler","is_ca":false},{"name":"Anna Dudek","is_ca":false},{"name":"Jacek C. Szepietowski","is_ca":false},{"name":"Nataliya Reznichenko","is_ca":false},{"name":"Joanna Narbutt","is_ca":false},{"name":"Wojciech Baran","is_ca":false},{"name":"Joanna Kolinek","is_ca":false},{"name":"Stefan Daniluk","is_ca":false},{"name":"Katarzyna Bartnicka-Maslowska","is_ca":false},{"name":"Adam Reich","is_ca":false},{"name":"Yuriy Andrashko","is_ca":false},{"name":"SungHyun Kim","is_ca":false},{"name":"Yunju Bae","is_ca":false},{"name":"DaBee Jeon","is_ca":false},{"name":"Jinsun Jung","is_ca":false},{"name":"Hyunseung Lee","is_ca":false},{"name":"Tina Pyo","is_ca":false},{"name":"Woori Ko","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04463726408912411,"gpt":0.3397974502253265,"spread":0.2951601861362024,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005466865,0.001814577,0.003969222,0.0005101815,0.000623635,0.001291398,0.001428062,0.002858798,0.004673449],"category_scores_gemma":[0.003770991,0.0009848516,0.002983663,0.0004648465,0.00218718,0.001556003,0.0005095502,0.004577389,0.001064794],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000863954,"about_ca_system_score_gemma":0.001831059,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005988009,"about_ca_topic_score_gemma":0.0009649368,"domain_scores_codex":[0.9978135,0.001291465,0.0001473938,0.0002672129,0.0002416894,0.0002387151],"domain_scores_gemma":[0.9963436,0.0009999048,0.0008691115,0.0004103907,0.000285022,0.001092046],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9365048,0.03513909,0.0006098219,0.0004668491,0.0007216245,0.00005629962,0.0001629385,0.000470773,0.01363605,0.00006451208,0.0005257823,0.01164141],"study_design_scores_gemma":[0.7191408,0.2754957,0.002514612,0.00002462395,0.0003419043,0.00007137042,0.00002394208,0.0003392352,0.001600542,0.00009682884,0.0003283921,0.0000220273],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933629,0.001428757,0.0008101392,0.0002196412,0.0001303444,0.002718772,0.0004711644,0.00008286766,0.0007754336],"genre_scores_gemma":[0.9919012,0.001075886,0.001450568,0.0005622917,0.0002500123,0.002438464,0.0007450014,0.00003860053,0.001537983],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005466865,"threshold_uncertainty_score":0.02891189,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2905052297","doi":"10.1007/s40259-018-0325-y","title":"Lanadelumab for the Prophylactic Treatment of Hereditary Angioedema with C1 Inhibitor Deficiency: A Review of Preclinical and Phase I Studies","year":2018,"lang":"en","type":"review","venue":"BioDrugs","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Hereditary angioedema; Medicine; C1-inhibitor; Dosing; Tolerability; Kallikrein; Pharmacokinetics; Angioedema; Pharmacology; Pharmacodynamics; Internal medicine; Immunology; Adverse effect","authors":[{"name":"Paula J. Busse","is_ca":false},{"name":"Henriette Farkas","is_ca":false},{"name":"Aleena Banerji","is_ca":false},{"name":"William R. Lumry","is_ca":false},{"name":"Hilary Longhurst","is_ca":false},{"name":"Dan Sexton","is_ca":false},{"name":"Marc A. Riedl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1589567030262765,"gpt":0.4415890634976389,"spread":0.2826323604713624,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001779275,0.0007539931,0.001945534,0.001492122,0.0002650432,0.001165476,0.001296001,0.001167785,0.003253832],"category_scores_gemma":[0.002023237,0.0003377145,0.001750926,0.001110587,0.0003960686,0.00124221,0.0004518754,0.002016972,0.0007722559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00053778,"about_ca_system_score_gemma":0.0009852195,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007783326,"about_ca_topic_score_gemma":0.00169708,"domain_scores_codex":[0.99965,0.00009473244,0.00008322689,0.0000491211,0.00009420909,0.00002867018],"domain_scores_gemma":[0.9988631,0.0006320641,0.0001805355,0.00002273126,0.0002330989,0.00006849526],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000853376,0.0003103213,0.0003978991,0.05437794,0.0006989256,0.000224912,0.0001217666,0.0004219267,0.002844208,0.001748555,0.02511771,0.9128824],"study_design_scores_gemma":[0.001494834,0.00318875,0.003359681,0.03860478,0.003644435,0.002702722,0.0001512937,0.0005005554,0.001921899,0.001839289,0.9425056,0.00008611797],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0004316903,0.998148,0.0001334534,0.0003553816,0.0001480829,0.00003713965,0.00004521578,0.000008942582,0.0006921162],"genre_scores_gemma":[0.00302536,0.9950971,0.0004070372,0.0007745334,0.0001924494,0.00006645028,0.00009088517,0.000004280395,0.0003419666],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003253832,"threshold_uncertainty_score":0.01088512,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4310776690","doi":"10.1007/s40259-022-00568-0","title":"The Global Landscape of Manufacturers of Follow-on Biologics: An Overview of Five Major Biosimilar Markets and 15 Countries","year":2022,"lang":"en","type":"article","venue":"BioDrugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biosimilar; China; Medicine; Biopharmaceutical; European union; Business; Product (mathematics); International trade; Biotechnology; Geography","authors":[{"name":"Kevin Klein","is_ca":false},{"name":"Mümün Gencoglu","is_ca":false},{"name":"Jens Heisterberg","is_ca":false},{"name":"Virginia Acha","is_ca":false},{"name":"Pieter Stolk","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02814807893878446,"gpt":0.2996754926621776,"spread":0.2715274137233932,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002221211,0.0002107106,0.0002524044,0.004730948,0.0004187468,0.001408647,0.0003070561,0.0003844456,0.002656759],"category_scores_gemma":[0.003607365,0.0001731177,0.0005681223,0.006942431,0.0004270265,0.001538912,0.001071715,0.0003563484,0.0003592392],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005488165,"about_ca_system_score_gemma":0.0007771075,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001799831,"about_ca_topic_score_gemma":0.002300528,"domain_scores_codex":[0.9980439,0.0004782037,0.0003938538,0.0004045808,0.000426707,0.0002528269],"domain_scores_gemma":[0.9907072,0.00188652,0.006012295,0.0001814254,0.0007225767,0.0004900547],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000170233,0.00003512521,0.9732887,0.0002872351,0.0001432424,0.0002796309,0.0008595072,0.0001112922,0.0005131601,0.000642732,0.001243687,0.02242542],"study_design_scores_gemma":[0.00001295163,0.0001363627,0.9830121,0.0003450369,0.0001432726,0.001432911,0.003685087,0.0001940083,0.0004852371,0.0001639573,0.01037397,0.00001502145],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.9789329,0.01207867,0.0003150095,0.0008543514,0.00001149042,0.00004013063,0.003088214,0.00002145386,0.00465779],"genre_scores_gemma":[0.9909456,0.00551129,0.0007279196,0.0003163594,0.0000163977,0.00003952305,0.002089175,0.000009298116,0.0003444095],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.004730948,"threshold_uncertainty_score":0.011747,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2024217378","doi":"10.2165/00063030-200014020-00006","title":"Photodynamic Therapy in Immune (Non-Oncological) Disorders","year":2000,"lang":"en","type":"article","venue":"BioDrugs","topic":"Photodynamic Therapy Research Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; QLT (Canada)","funders":"","keywords":"Photodynamic therapy; Verteporfin; Medicine; Immune system; Cancer research; Immunology; Chemistry; Surgery","authors":[{"name":"Leslie G. Ratkay","is_ca":true},{"name":"J. Douglas Waterfield","is_ca":true},{"name":"David W. C. Hunt","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01153634557335672,"gpt":0.3003189062959898,"spread":0.2887825607226331,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001100261,0.0002679532,0.0002920389,0.0006665753,0.0003628153,0.0004333829,0.0002767174,0.0005917185,0.002746243],"category_scores_gemma":[0.0004511754,0.0000908866,0.0002597054,0.0004234956,0.0005891504,0.0006542534,0.0003033408,0.0004692678,0.0003365549],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004183695,"about_ca_system_score_gemma":0.0003741293,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005366735,"about_ca_topic_score_gemma":0.0004643215,"domain_scores_codex":[0.9997966,0.00009734596,0.00001617267,0.0000218261,0.00002245667,0.00004569324],"domain_scores_gemma":[0.9998071,0.0001102964,0.00002749063,0.00002318568,0.00001634325,0.00001565365],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008267261,0.006341934,0.005962791,0.003240719,0.0001559878,0.002721593,0.001096141,0.000649344,0.6340362,0.03492341,0.003463312,0.2991413],"study_design_scores_gemma":[0.001221147,0.01989948,0.02010736,0.0005382712,0.0003721936,0.01070474,0.001108775,0.0006516972,0.8190947,0.006862513,0.1194074,0.00003173887],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.7255576,0.246727,0.002811882,0.001455177,0.0002987536,0.0002072736,0.00009810221,0.00003251144,0.02281167],"genre_scores_gemma":[0.9061249,0.08010144,0.002798956,0.0005637587,0.0002366837,0.0001781671,0.0001242474,0.00001189659,0.009859944],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.002746243,"threshold_uncertainty_score":0.009187162,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W204758488","doi":"10.2165/00063030-200721010-00002","title":"Therapeutic and Prophylactic Potential of Small Interfering RNAs against Severe Acute Respiratory Syndrome","year":2007,"lang":"en","type":"review","venue":"BioDrugs","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto; University of Saskatchewan","funders":"Canadian Institutes of Health Research","keywords":"Small interfering RNA; RNA interference; Virology; RNA; Biology; Medicine; Coronavirus; Immunology; Coronavirus disease 2019 (COVID-19); Gene; Infectious disease (medical specialty); Pathology; Disease","authors":[{"name":"Zhijie Chang","is_ca":false},{"name":"Lorne A. Babiuk","is_ca":true},{"name":"Jim Hu","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0431896343897843,"gpt":0.3051160456634367,"spread":0.2619264112736524,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005024978,0.0008651617,0.001302851,0.001039883,0.0002234434,0.0006146037,0.0008775913,0.001204947,0.001917586],"category_scores_gemma":[0.0003649169,0.0002228203,0.0003365632,0.0008636338,0.0005002133,0.0006345157,0.000354387,0.001479854,0.001183912],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004260602,"about_ca_system_score_gemma":0.0004630505,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004659533,"about_ca_topic_score_gemma":0.0008252343,"domain_scores_codex":[0.9998723,0.00001991693,0.00001418335,0.00001935156,0.00005758739,0.00001659444],"domain_scores_gemma":[0.9998574,0.00007814346,0.00002068267,0.000004914008,0.00002814123,0.00001059148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001555709,0.0001219653,0.0001162793,0.003755178,0.00004796171,0.0004114497,0.00003605459,0.000607543,0.01471222,0.004225838,0.01101455,0.9647955],"study_design_scores_gemma":[0.0001047581,0.0003746069,0.0009930182,0.001007234,0.0001419624,0.003562343,0.00004248192,0.0004324612,0.01008873,0.002784884,0.9804348,0.00003282388],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000746661,0.9952183,0.001188481,0.0003283204,0.0003139189,0.00001307024,0.00002025556,0.00002496793,0.002145938],"genre_scores_gemma":[0.004484117,0.9910784,0.001487734,0.0003720613,0.0002895398,0.00003344323,0.0000676299,0.000004928231,0.002182109],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001917586,"threshold_uncertainty_score":0.00641489,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2961547340","doi":"10.1007/s40259-019-00366-1","title":"Factors Influencing Drug Disposition of Monoclonal Antibodies in Inflammatory Bowel Disease: Implications for Personalized Medicine","year":2019,"lang":"en","type":"review","venue":"BioDrugs","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Medicine; Inflammatory bowel disease; Ulcerative colitis; Drug; Therapeutic drug monitoring; Personalized medicine; Monoclonal antibody; Pharmacodynamics; Dosing; Pharmacokinetics; Crohn's disease; Precision medicine; Efficacy; Disease; Pharmacotherapy; Pharmacology; Immunology; Intensive care medicine; Internal medicine; Bioinformatics; Antibody; Pathology","authors":[{"name":"Pavine Lefèvre","is_ca":true},{"name":"Lisa M. Shackelton","is_ca":true},{"name":"Niels Vande Casteele","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1079329269223195,"gpt":0.4040673753673309,"spread":0.2961344484450115,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007754379,0.0005808015,0.001611311,0.001258645,0.0001166102,0.001013437,0.0005593006,0.0009280935,0.002269437],"category_scores_gemma":[0.001601352,0.0001836416,0.0008537816,0.001573158,0.0003599809,0.0008082103,0.0004050761,0.001256309,0.0005372436],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004702292,"about_ca_system_score_gemma":0.0009233843,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0012678,"about_ca_topic_score_gemma":0.002230101,"domain_scores_codex":[0.9997662,0.00006239453,0.00004193899,0.00004952515,0.00006241733,0.00001749478],"domain_scores_gemma":[0.9990008,0.0006916857,0.0001552953,0.00001438862,0.0001126456,0.00002513504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002450831,0.0001018106,0.001453878,0.02093496,0.0005278279,0.0001669297,0.00003360222,0.0004149133,0.0008800462,0.001897935,0.01087227,0.9624707],"study_design_scores_gemma":[0.0002029931,0.0006634135,0.01279156,0.02115396,0.003428175,0.002938858,0.0002051428,0.0006631696,0.001475084,0.007016886,0.9493522,0.0001084928],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001517543,0.9993773,0.00006024288,0.0001622757,0.00005097056,0.000001526882,0.00001481783,0.000001836324,0.0001792524],"genre_scores_gemma":[0.001063738,0.9983482,0.0001329486,0.0001757936,0.0001310372,0.000003430066,0.00002083249,5.410367e-7,0.0001234108],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002269437,"threshold_uncertainty_score":0.007592082,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2073194177","doi":"10.2165/00063030-200620010-00001","title":"The Future of Antisense Oligonucleotides in the Treatment of Respiratory Diseases","year":2006,"lang":"en","type":"review","venue":"BioDrugs","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"NOSM University; University of Alberta","funders":"National Heart, Lung, and Blood Institute","keywords":"Oligonucleotide; Genetic enhancement; Small interfering RNA; RNA interference; RNA; Immune system; Biology; Translation (biology); Medicine; Pharmacology; Messenger RNA; Computational biology; Gene; Immunology; Genetics","authors":[{"name":"Marina Ulanova","is_ca":true},{"name":"Alan D. Schreiber","is_ca":false},{"name":"A. Dean Befus","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02334919196402986,"gpt":0.3058975377542738,"spread":0.282548345790244,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001152664,0.001145843,0.00179481,0.00138923,0.0003632618,0.001108657,0.001461145,0.00208781,0.003407906],"category_scores_gemma":[0.0005581963,0.0003539616,0.0004757763,0.001380956,0.0009184713,0.002157359,0.0005981786,0.002739101,0.002361085],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000842428,"about_ca_system_score_gemma":0.0009154084,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009622602,"about_ca_topic_score_gemma":0.002305159,"domain_scores_codex":[0.9997852,0.00004406715,0.00002216262,0.00003312763,0.00009054651,0.00002486145],"domain_scores_gemma":[0.9997191,0.0001426056,0.00003542606,0.000007620964,0.00006421748,0.00003100785],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002306247,0.0001552715,0.0001180003,0.006503966,0.0000702371,0.0004302654,0.00007413318,0.0009782361,0.01276863,0.009931551,0.02788503,0.940854],"study_design_scores_gemma":[0.00008277588,0.000248777,0.0003435391,0.0009047556,0.00007975882,0.001449916,0.00005507671,0.00038674,0.002196403,0.004351832,0.9898733,0.00002707962],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001952569,0.9967398,0.0009684993,0.0005706737,0.0004551654,0.000006546844,0.00001052387,0.00001897927,0.001034532],"genre_scores_gemma":[0.001212281,0.9957628,0.001051881,0.0003953377,0.0003546973,0.00001505601,0.00002348381,0.00000302137,0.001181323],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003407906,"threshold_uncertainty_score":0.01140052,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1990941062","doi":"10.2165/00063030-200822040-00005","title":"Anti-Adhesion Molecule Strategies for Crohn Disease","year":2008,"lang":"en","type":"review","venue":"BioDrugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Infliximab; Crohn's disease; Adalimumab; Medicine; Monoclonal antibody; Disease; Tumor necrosis factor alpha; Monoclonal antibody therapy; Inflammatory bowel disease; Immunology; Monoclonal; Certolizumab pegol; Antibody; Internal medicine","authors":[{"name":"Yvette Leung","is_ca":true},{"name":"Remo Panaccione","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02500131258589668,"gpt":0.3008105274606349,"spread":0.2758092148747383,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001008313,0.001168301,0.001777335,0.001460108,0.0003228145,0.001149826,0.001232547,0.001728251,0.002573634],"category_scores_gemma":[0.0007567662,0.0003704055,0.0005409007,0.001276155,0.0008545317,0.001473121,0.0006604642,0.003876613,0.001964705],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000744259,"about_ca_system_score_gemma":0.0006653335,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000780121,"about_ca_topic_score_gemma":0.00202128,"domain_scores_codex":[0.9998273,0.0000314666,0.00002146795,0.0000273667,0.00006725555,0.00002523941],"domain_scores_gemma":[0.9997255,0.0001380659,0.00003036935,0.00001010079,0.00006564906,0.00003023428],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002385719,0.0001832784,0.0001346136,0.006000093,0.0001021305,0.0004122588,0.00004661698,0.0009019214,0.004669979,0.008803548,0.06498958,0.9135175],"study_design_scores_gemma":[0.00009000883,0.0001321697,0.0003230936,0.0009532929,0.00008845716,0.0009270188,0.00003169995,0.0001746456,0.0008924371,0.002730405,0.9936407,0.0000159819],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001651065,0.9971041,0.0004451521,0.0005033787,0.0006606504,0.000008528173,0.00001633911,0.0000137715,0.00108288],"genre_scores_gemma":[0.001087478,0.995659,0.000738359,0.0005408295,0.000451858,0.00002093335,0.00004250429,0.000003127398,0.001455981],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002573634,"threshold_uncertainty_score":0.008609653,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3167186946","doi":"10.1007/s40259-021-00486-7","title":"Restoring Protein Expression in Neuromuscular Conditions: A Review Assessing the Current State of Exon Skipping/Inclusion and Gene Therapies for Duchenne Muscular Dystrophy and Spinal Muscular Atrophy","year":2021,"lang":"en","type":"review","venue":"BioDrugs","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"Women and Children's Health Research Institute","keywords":"Spinal muscular atrophy; Duchenne muscular dystrophy; SMA*; Exon skipping; Medicine; Dystrophin; Neuromuscular disease; Muscular dystrophy; Antisense therapy; Motor neuron; Weakness; Bioinformatics; Genetic enhancement; Exon; Internal medicine; Disease; Biology; Surgery; Genetics; Gene; microRNA; Alternative splicing","authors":[{"name":"Omar Sheikh","is_ca":true},{"name":"Toshifumi Yokota","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0616848120403912,"gpt":0.4081047040783568,"spread":0.3464198920379656,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009757669,0.0009053741,0.002602758,0.002297925,0.000204144,0.001186285,0.001042198,0.001266299,0.003375878],"category_scores_gemma":[0.001131295,0.00035065,0.00102011,0.002163436,0.0004404179,0.001209366,0.0006016275,0.001804416,0.001196094],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004353566,"about_ca_system_score_gemma":0.001043002,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009668929,"about_ca_topic_score_gemma":0.002097021,"domain_scores_codex":[0.9997439,0.00004389144,0.00006107378,0.00004443636,0.00008504173,0.00002172223],"domain_scores_gemma":[0.9993594,0.0004503902,0.00007626427,0.00001095725,0.00007789032,0.00002505267],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002239709,0.00009256473,0.0001619465,0.06819502,0.0003152736,0.0002380282,0.00006806769,0.000366096,0.002950395,0.001869954,0.01791592,0.9076027],"study_design_scores_gemma":[0.0001264122,0.0003327832,0.001210287,0.01681445,0.001273278,0.001770599,0.00008826651,0.0001623477,0.001149182,0.00147209,0.9755532,0.00004719212],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00006250155,0.9995658,0.00006045656,0.00006010543,0.00005957407,0.000003408122,0.00001696372,0.000003007754,0.0001680887],"genre_scores_gemma":[0.0003012544,0.9992326,0.0001380826,0.0001156487,0.00004608823,0.00000520657,0.00002672543,9.53879e-7,0.0001333672],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003375878,"threshold_uncertainty_score":0.01129347,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2029930411","doi":"10.1007/s40259-014-0099-9","title":"Similar Names for Similar Biologics","year":2014,"lang":"en","type":"article","venue":"BioDrugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":14,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"Amicus Therapeutics; Amgen","keywords":"Biosimilar; Pharmacovigilance; Interchangeability; Medicine; Product (mathematics); Pharmacology; Computer science; Adverse effect","authors":[{"name":"Nicole Casadevall","is_ca":false},{"name":"Thomas Felix","is_ca":false},{"name":"Bruce Strober","is_ca":true},{"name":"David G. Warnock","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02234148561895411,"gpt":0.2784489941231749,"spread":0.2561075085042208,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001432811,0.001468189,0.001109783,0.003248692,0.002050909,0.003537575,0.001426942,0.002446962,0.04847387],"category_scores_gemma":[0.004850835,0.0003444187,0.001424766,0.004956887,0.003952804,0.005363673,0.002492184,0.004962626,0.03359335],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001214711,"about_ca_system_score_gemma":0.001566196,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006171754,"about_ca_topic_score_gemma":0.0009706504,"domain_scores_codex":[0.9978971,0.0006203998,0.0003116405,0.0004081961,0.0004513142,0.0003112909],"domain_scores_gemma":[0.9958389,0.001385366,0.000781982,0.0007532776,0.0008566261,0.0003839474],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","study_design_scores_codex":[0.0003569894,0.0001114213,0.0005053623,0.00189706,0.00009114343,0.001088007,0.0008381646,0.0003469943,0.01123473,0.5052488,0.2783915,0.1998898],"study_design_scores_gemma":[0.00001028898,0.00004198464,0.0001605501,0.00009214657,0.00001463789,0.0007415085,0.0001023786,0.00009903614,0.001106268,0.01254929,0.9850689,0.0000131033],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.01799577,0.07057581,0.1724901,0.0211304,0.1476137,0.0008258478,0.005078983,0.00441995,0.5598694],"genre_scores_gemma":[0.1424744,0.06062271,0.1973697,0.03177575,0.02357767,0.001294453,0.01161624,0.003304704,0.5279644],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.04847387,"threshold_uncertainty_score":0.1621612,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4404773045","doi":"10.1007/s40259-024-00687-w","title":"Interleukin-17 Inhibitors in the Treatment of Hidradenitis Suppurativa","year":2024,"lang":"en","type":"review","venue":"BioDrugs","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Saskatchewan","funders":"Fundação para a Ciência e a Tecnologia; Universidade do Porto","keywords":"Medicine; Secukinumab; Hidradenitis suppurativa; Clinical trial; Dermatology; Quality of life (healthcare); Psoriasis; Pharmacology; Intensive care medicine; Disease; Internal medicine; Psoriatic arthritis","authors":[{"name":"Gonçalo Pinto Salgueiro","is_ca":false},{"name":"Orhan Yılmaz","is_ca":true},{"name":"Miguel Nogueira","is_ca":false},{"name":"Tiago Torres","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06812192845542084,"gpt":0.3786615047880245,"spread":0.3105395763326037,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003424248,0.0003121221,0.0006315657,0.0006675899,0.0001408059,0.0004683946,0.0003198814,0.0004292889,0.002562574],"category_scores_gemma":[0.0003816749,0.00009087914,0.0005452389,0.000410248,0.0001417139,0.000373649,0.0002896652,0.001154447,0.0006262326],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002033157,"about_ca_system_score_gemma":0.0003508529,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003170176,"about_ca_topic_score_gemma":0.001153473,"domain_scores_codex":[0.9998255,0.00005072941,0.00002976724,0.00002054072,0.00005002787,0.00002331014],"domain_scores_gemma":[0.9998738,0.00005484637,0.00003363124,0.000002833841,0.00002268311,0.00001228004],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0006990691,0.0002293332,0.0004371497,0.01621815,0.0002626246,0.0005759985,0.0001053974,0.0004376129,0.006572613,0.001750561,0.01624686,0.9564648],"study_design_scores_gemma":[0.0006757308,0.001879774,0.004889892,0.008005496,0.0008127242,0.004782665,0.0001614473,0.000472772,0.004105903,0.001820885,0.972348,0.00004463661],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001554757,0.9964926,0.0001551073,0.0002972767,0.0001866585,0.00001312993,0.00003647606,0.00001496825,0.001248901],"genre_scores_gemma":[0.01901335,0.9775609,0.0006296946,0.0008223637,0.0004566487,0.00003944538,0.0001727546,0.000005202687,0.001299664],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002562574,"threshold_uncertainty_score":0.008572698,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2030438860","doi":"10.2165/11206830-000000000-00000","title":"Spotlight on AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®)†","year":2011,"lang":"en","type":"article","venue":"BioDrugs","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"","keywords":"Immunogenicity; Medicine; Cervical cancer; Virology; Adjuvant; Immunology; Cervical intraepithelial neoplasia; HPV vaccines; DNA vaccination; Immune system; Vaccination; HPV infection; Immunization; Cancer; Internal medicine","authors":[{"name":"Kate McKeage","is_ca":false},{"name":"Barbara Romanowski","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08524794751241882,"gpt":0.3382199901668697,"spread":0.2529720426544509,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002295919,0.0006572407,0.0008621784,0.0005286842,0.0005243581,0.00136219,0.0008062035,0.004209957,0.01993473],"category_scores_gemma":[0.00166181,0.0002995458,0.0006252069,0.0005144096,0.0006814363,0.001559229,0.000618937,0.002901495,0.004906267],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008651262,"about_ca_system_score_gemma":0.001949171,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00162085,"about_ca_topic_score_gemma":0.002957547,"domain_scores_codex":[0.9993493,0.0001407014,0.00005089991,0.000102992,0.0002111711,0.0001449637],"domain_scores_gemma":[0.9984505,0.0004940181,0.0001225747,0.00003572259,0.0006087444,0.0002883964],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002775982,0.000421617,0.0004952853,0.002568046,0.00005240968,0.0003922042,0.00008014402,0.0004873232,0.04122955,0.007727487,0.4214121,0.5223579],"study_design_scores_gemma":[0.0003147004,0.002524842,0.001015194,0.0005437853,0.00008604857,0.000498213,0.0001151097,0.0005240519,0.01377743,0.003049525,0.9775163,0.00003470416],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"editorial","genre_scores_codex":[0.02918601,0.587873,0.008649261,0.2239234,0.0780936,0.0005096777,0.002171677,0.0006801087,0.06891325],"genre_scores_gemma":[0.103015,0.4780478,0.01147503,0.1630238,0.04852172,0.0006220305,0.002921318,0.0002705457,0.1921027],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.01993473,"threshold_uncertainty_score":0.06668824,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2012092068","doi":"10.2165/00063030-200317001-00006","title":"Current Status and Replies to Frequently Posed Questions on Atovaquone Plus Proguanil (Malarone??) for the Prevention of Malaria","year":2003,"lang":"en","type":"review","venue":"BioDrugs","topic":"Malaria Research and Control","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Proguanil; Malaria; Atovaquone; Mefloquine; Medicine; Chloroquine; Chemoprophylaxis; Malaria prophylaxis; Artemisinin; Intensive care medicine; Primaquine; Plasmodium falciparum; Pharmacology; Immunology; Internal medicine","authors":[{"name":"Kevin C. Kain","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07494769191811303,"gpt":0.3959982805013508,"spread":0.3210505885832378,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002403235,0.0006116885,0.002323283,0.002299289,0.0003387614,0.001744609,0.0009497599,0.002108848,0.006684823],"category_scores_gemma":[0.006020713,0.0003964728,0.0009135085,0.00413136,0.0005547659,0.002034542,0.0007136246,0.001705582,0.002281393],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008348858,"about_ca_system_score_gemma":0.001791319,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002177179,"about_ca_topic_score_gemma":0.005287946,"domain_scores_codex":[0.9994639,0.0001339536,0.0001396964,0.00006117983,0.0001657095,0.00003568799],"domain_scores_gemma":[0.9960334,0.002705803,0.0005777327,0.00003281857,0.0005568853,0.0000933186],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003431207,0.00004045362,0.0002875336,0.04114815,0.0001656938,0.0001990335,0.0001747525,0.0001877562,0.000824928,0.001395533,0.06764306,0.8875899],"study_design_scores_gemma":[0.00007878758,0.000182497,0.001207651,0.01976038,0.0006069336,0.0007932226,0.000324621,0.00007408428,0.0004049308,0.0009093983,0.9756267,0.0000307312],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001305057,0.9964362,0.00004482226,0.002000758,0.0005507589,0.000006352434,0.00004864009,0.000003469654,0.0007784397],"genre_scores_gemma":[0.0006629543,0.9970336,0.0001214016,0.001085014,0.0004307755,0.00001004251,0.00005866737,0.000001543047,0.0005960359],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.006684823,"threshold_uncertainty_score":0.02236289,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4389486878","doi":"10.1007/s40259-023-00636-z","title":"Is the Availability of Biosimilar Adalimumab Associated with Budget Savings? A Difference-in-Difference Analysis of 14 Countries","year":2023,"lang":"en","type":"article","venue":"BioDrugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"National Research Foundation of Korea","keywords":"Biosimilar; Adalimumab; Medicine; Significant difference; Intensive care medicine; Internal medicine; Rheumatoid arthritis","authors":[{"name":"Hyunjung Woo","is_ca":false},{"name":"Gyeongseon Shin","is_ca":false},{"name":"Donghwan Lee","is_ca":false},{"name":"Hye-Young Kwon","is_ca":false},{"name":"SeungJin Bae","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02774255390288685,"gpt":0.2830068196293937,"spread":0.2552642657265068,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01461385,0.0007517425,0.001890472,0.00123281,0.000243375,0.001320906,0.001052174,0.0007234039,0.002103563],"category_scores_gemma":[0.01740623,0.0004864573,0.009574703,0.00163244,0.0007850148,0.0006888155,0.001727871,0.001525263,0.000166941],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007339634,"about_ca_system_score_gemma":0.0007625198,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008967282,"about_ca_topic_score_gemma":0.004403824,"domain_scores_codex":[0.9775401,0.01713871,0.001329573,0.001816337,0.0008474426,0.001327744],"domain_scores_gemma":[0.981384,0.01254363,0.003662809,0.001270974,0.0005837509,0.0005547569],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0112804,0.0003172827,0.9278827,0.0006641876,0.03766897,0.0005084685,0.0002033128,0.01153372,0.001193049,0.0006663977,0.0007921854,0.007289367],"study_design_scores_gemma":[0.0009675086,0.003766387,0.9416162,0.0002542535,0.01545018,0.0004055114,0.001148863,0.03064825,0.001758899,0.0006373647,0.003245756,0.0001008337],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941114,0.001854455,0.001689728,0.0001988779,0.00008854693,0.00008992805,0.001527814,0.00001712009,0.0004220983],"genre_scores_gemma":[0.9978067,0.0001720412,0.0005630361,0.000107052,0.00001903138,0.00007763162,0.001089139,0.00000772869,0.0001575723],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01461385,"threshold_uncertainty_score":0.07728636,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W217783584","doi":"10.1007/s40259-015-0126-5","title":"Status and Prospects of Aptamers as Drug Components","year":2015,"lang":"en","type":"review","venue":"BioDrugs","topic":"Advanced biosensing and bioanalysis techniques","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Carleton University","funders":"","keywords":"Aptamer; Drug; Pharmacotherapy; Medicine; Computational biology; Intensive care medicine; Pharmacology; Biology; Internal medicine; Genetics","authors":[{"name":"Christopher Mattice","is_ca":true},{"name":"Maria C. DeRosa","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02908022629780935,"gpt":0.335241854693982,"spread":0.3061616283961726,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007594556,0.000885843,0.001087516,0.001514747,0.0002132235,0.001304371,0.000923675,0.001356839,0.00305885],"category_scores_gemma":[0.0007364229,0.0003975669,0.0004541581,0.001652485,0.0006723086,0.001898309,0.0009749611,0.00153683,0.001900206],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004665286,"about_ca_system_score_gemma":0.0006729593,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005054082,"about_ca_topic_score_gemma":0.0007939542,"domain_scores_codex":[0.9997757,0.00003543435,0.00002465191,0.00005170725,0.0000809449,0.00003159129],"domain_scores_gemma":[0.9996934,0.0001699047,0.00004815675,0.00001274832,0.00005112677,0.00002474008],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009534609,0.00009992984,0.0002321687,0.009581142,0.00005012105,0.0002114373,0.00006963771,0.0006597606,0.01110663,0.009535737,0.01067048,0.9576877],"study_design_scores_gemma":[0.00001649538,0.0001392623,0.0004474849,0.001153384,0.00007739222,0.0009227245,0.00005049969,0.0003071009,0.004274088,0.003681891,0.9889059,0.00002377374],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002988923,0.9978573,0.000455123,0.0001634348,0.0001274946,0.000003756729,0.00001267702,0.000006742679,0.001074545],"genre_scores_gemma":[0.002009017,0.9956785,0.0006467375,0.0002507254,0.0001857044,0.000008679986,0.00002805249,0.000002530697,0.001190053],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00305885,"threshold_uncertainty_score":0.01023287,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4360601016","doi":"10.1007/s40259-023-00589-3","title":"Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis","year":2023,"lang":"en","type":"article","venue":"BioDrugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Health and Medical Research Fund; Medical Research Council; University of Hong Kong; National Institute for Health and Care Research; Australian Government; National Health and Medical Research Council; European Commission; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Biosimilar; Infliximab; Medicine; Interrupted time series; Interrupted Time Series Analysis; Consumption (sociology); Demography; Internal medicine; Tumor necrosis factor alpha","authors":[{"name":"Kuan Peng","is_ca":false},{"name":"Joseph E. Blais","is_ca":false},{"name":"Nicole Pratt","is_ca":false},{"name":"Jeff J. Guo","is_ca":false},{"name":"Jodie Hillen","is_ca":false},{"name":"Ty Stanford","is_ca":false},{"name":"Michael Ward","is_ca":false},{"name":"Edward Chia‐Cheng Lai","is_ca":false},{"name":"Ju‐Young Shin","is_ca":false},{"name":"Xinning Tong","is_ca":false},{"name":"Min Fan","is_ca":false},{"name":"Franco Wing Tak Cheng","is_ca":false},{"name":"Jing Cynthia Wu","is_ca":false},{"name":"Winnie W. Y. Yeung","is_ca":false},{"name":"Wai K. Leung","is_ca":false},{"name":"Ian Chi Kei Wong","is_ca":false},{"name":"Xue Li","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02306556960911271,"gpt":0.3292944411009679,"spread":0.3062288714918552,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003124425,0.0002679264,0.000557267,0.0007503697,0.0001446069,0.0009176129,0.000535585,0.0004478616,0.001066874],"category_scores_gemma":[0.007930735,0.0002024261,0.001606846,0.001733316,0.0003005699,0.0004078747,0.0004850742,0.000784192,0.0001770623],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008372806,"about_ca_system_score_gemma":0.0007121846,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02510648,"about_ca_topic_score_gemma":0.01142612,"domain_scores_codex":[0.99762,0.001103675,0.0002252235,0.0004710699,0.0003386799,0.00024122],"domain_scores_gemma":[0.9918672,0.002762317,0.003677534,0.0004878636,0.0008514356,0.0003536535],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001804289,0.0001487215,0.9853976,0.00009704108,0.001295833,0.0002441025,0.0004025259,0.003553875,0.0008934648,0.0001568113,0.0002875194,0.005718084],"study_design_scores_gemma":[0.00002693265,0.0003524259,0.9887228,0.00001755601,0.0004355835,0.0001000949,0.0002943272,0.009161774,0.0003611752,0.00004537508,0.0004659875,0.00001599285],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977351,0.0003154996,0.0006400492,0.0000589291,0.00001037048,0.00001244901,0.000939257,0.000008410103,0.0002799704],"genre_scores_gemma":[0.9976225,0.0001572159,0.000435632,0.00002936119,0.000007599088,0.00002295737,0.00140956,0.000005161763,0.0003100774],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02510648,"threshold_uncertainty_score":0.04992068,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2009690780","doi":"10.2165/00063030-200418020-00001","title":"Business Ethics 101 for the Biotech Industry","year":2004,"lang":"en","type":"review","venue":"BioDrugs","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Saint Mary's University","funders":"","keywords":"Drug industry; Business ethics; Business; Management; Biotechnology; Engineering ethics; Medicine; Biology; Engineering; Economics","authors":[{"name":"Chris MacDonald","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.120024753410699,"gpt":0.3866064633007289,"spread":0.2665817098900299,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004775179,0.001073043,0.001557637,0.002498336,0.001212208,0.003973123,0.001203542,0.009182724,0.003986659],"category_scores_gemma":[0.008352148,0.0004315449,0.0006832838,0.002799047,0.002986972,0.002898283,0.001331872,0.005300266,0.002016785],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004533234,"about_ca_system_score_gemma":0.01106869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006070676,"about_ca_topic_score_gemma":0.01146944,"domain_scores_codex":[0.9961708,0.001740146,0.000232769,0.0002197281,0.001430286,0.0002062403],"domain_scores_gemma":[0.9958877,0.002548428,0.0003321946,0.0001484236,0.0009359304,0.0001472846],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005130685,0.00007602188,0.000214352,0.006500055,0.00006979541,0.0007533783,0.0003210825,0.0004955553,0.0007246606,0.1191811,0.3566445,0.5149682],"study_design_scores_gemma":[0.00001286314,0.00001720968,0.0002889382,0.003901095,0.00002130359,0.0004431885,0.00008307329,0.00004091068,0.00009159735,0.01087251,0.9842195,0.000007741447],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002012039,0.9473218,0.0006467357,0.02299869,0.00247429,0.00002508511,0.00001838103,0.00001529266,0.02629854],"genre_scores_gemma":[0.007615142,0.9074181,0.002166798,0.05162664,0.002346683,0.0001241129,0.00006542709,0.00001935696,0.02861776],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.009182724,"threshold_uncertainty_score":0.03289104,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4407184001","doi":"10.1007/s40259-025-00706-4","title":"TL1A Inhibition in Inflammatory Bowel Disease: A Pipeline Review","year":2025,"lang":"en","type":"review","venue":"BioDrugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Inflammatory bowel disease; Medicine; Molecular medicine; Internal medicine; Disease; Pharmacology; Bioinformatics; Biology","authors":[{"name":"Virginia Solitano","is_ca":true},{"name":"María Manuela Estevinho","is_ca":false},{"name":"Federica Ungaro","is_ca":true},{"name":"Fernando Magro","is_ca":false},{"name":"Silvio Danese","is_ca":true},{"name":"Vipul Jairath","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01137065343003696,"gpt":0.2901550140829343,"spread":0.2787843606528973,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008443837,0.001119372,0.002341341,0.00179827,0.0002488903,0.001252747,0.001079889,0.001336953,0.005332483],"category_scores_gemma":[0.0009717456,0.0003599708,0.0009747238,0.001553013,0.000439683,0.001156619,0.0008241609,0.003177727,0.002214956],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006006125,"about_ca_system_score_gemma":0.001202394,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008943893,"about_ca_topic_score_gemma":0.002414729,"domain_scores_codex":[0.999828,0.00003149126,0.00002400914,0.00003069147,0.00005631669,0.00002964564],"domain_scores_gemma":[0.9996629,0.0001651436,0.00004533293,0.000008665343,0.00007359489,0.00004442131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003712082,0.0001651266,0.0001017557,0.01913131,0.0001987879,0.0001864352,0.00003768204,0.0005532205,0.002511516,0.003347523,0.06051309,0.9128824],"study_design_scores_gemma":[0.0001967201,0.0004344097,0.0004670332,0.004755829,0.000445438,0.0006075406,0.00003745422,0.0001794717,0.0007921522,0.002054034,0.9899998,0.00003025173],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000111321,0.9984749,0.0001628027,0.0002874704,0.0003138547,0.00001098767,0.00004271578,0.00001422933,0.0005817768],"genre_scores_gemma":[0.0006109087,0.9979392,0.0002293501,0.0004102063,0.0001690796,0.00001611763,0.00006471963,0.000002893622,0.0005576305],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005332483,"threshold_uncertainty_score":0.0178389,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3132376226","doi":"10.1007/s40259-020-00464-5","title":"Maintaining Clinical Freedom Whilst Achieving Value in Biologics Prescribing: An Integrated Cross-Specialty Consensus of UK Dermatologists, Rheumatologists and Gastroenterologists","year":2021,"lang":"en","type":"article","venue":"BioDrugs","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Janssen UK; Arthritis Society; Psoriasis Association","keywords":"Medicine; Nice; Specialty; Excellence; Equity (law); Alternative medicine; Health care; Family medicine; Intensive care medicine; Political science","authors":[{"name":"Tim Raine","is_ca":false},{"name":"Maria Angeliki Gkini","is_ca":false},{"name":"Peter M. Irving","is_ca":false},{"name":"Arvind Kaul","is_ca":false},{"name":"Eleanor Korendowych","is_ca":false},{"name":"Philip Laws","is_ca":false},{"name":"Amy Foulkes","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04720052022437258,"gpt":0.3089021478445579,"spread":0.2617016276201853,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1102759,0.0004401607,0.00127994,0.002402212,0.007075939,0.01032185,0.002560619,0.008281696,0.003076472],"category_scores_gemma":[0.1309517,0.001123091,0.001084737,0.001453759,0.01147856,0.008362637,0.01798829,0.009574613,0.0007058763],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01122227,"about_ca_system_score_gemma":0.03288648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009459767,"about_ca_topic_score_gemma":0.01103001,"domain_scores_codex":[0.8457336,0.1023846,0.01529533,0.005624759,0.02081179,0.01014981],"domain_scores_gemma":[0.8121505,0.08415119,0.0137764,0.005182517,0.04524714,0.03949226],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"qualitative","study_design_gemma":"qualitative","study_design_scores_codex":[0.0002771028,0.00028254,0.02996046,0.003065938,0.0002026539,0.009190913,0.770214,0.0008846463,0.00538621,0.01250629,0.05364516,0.1143842],"study_design_scores_gemma":[0.000147067,0.0006301336,0.03226568,0.0079904,0.0001290382,0.00879867,0.7420029,0.002973846,0.001769334,0.02357633,0.1791981,0.0005185399],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.4276841,0.01759891,0.01386561,0.5150837,0.003888055,0.0008017283,0.0001128585,0.0001489543,0.02081625],"genre_scores_gemma":[0.9453449,0.0052809,0.01279271,0.0331368,0.0004488075,0.0002541786,0.00006764003,0.00005675556,0.002617232],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.1102759,"threshold_uncertainty_score":0.5832017,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2302684203","doi":"10.1007/s40259-016-0166-5","title":"Anti-EGFR Therapy for Metastatic Colorectal Cancer in the Era of Extended RAS Gene Mutational Analysis","year":2016,"lang":"en","type":"review","venue":"BioDrugs","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame","funders":"","keywords":"Panitumumab; KRAS; Cetuximab; Neuroblastoma RAS viral oncogene homolog; Colorectal cancer; Targeted therapy; Medicine; Oncology; Epidermal growth factor receptor; Oncogene; Cancer; Cancer research; Internal medicine","authors":[{"name":"Elie Kassouf","is_ca":true},{"name":"Samer Tabchi","is_ca":true},{"name":"Mustapha Tehfé","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05484679178644022,"gpt":0.3942189056036,"spread":0.3393721138171598,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004734423,0.0005508633,0.001580538,0.001386675,0.0001443872,0.0006127353,0.0006048705,0.0006474667,0.00245821],"category_scores_gemma":[0.0005838561,0.0002049369,0.0007735485,0.00113505,0.0002632446,0.0008037343,0.0003997081,0.001217658,0.0005529101],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003161185,"about_ca_system_score_gemma":0.0006170915,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006797233,"about_ca_topic_score_gemma":0.002329645,"domain_scores_codex":[0.999881,0.00002493519,0.00002354516,0.00001978176,0.00003747072,0.00001324692],"domain_scores_gemma":[0.9997843,0.0001306773,0.00004193775,0.000004403146,0.00002829735,0.00001043128],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002121553,0.00009694436,0.0001724479,0.03382542,0.0003090139,0.0002272461,0.00004363611,0.0003852929,0.001959931,0.001837737,0.01118324,0.949747],"study_design_scores_gemma":[0.0002212668,0.000625871,0.001848208,0.01408279,0.001494814,0.00282159,0.0001020421,0.0002721156,0.001615625,0.002157829,0.9747092,0.00004872027],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001968802,0.9992212,0.0000556277,0.0001005408,0.00004396272,0.000004679644,0.00001184892,0.000002407784,0.0003629588],"genre_scores_gemma":[0.001296969,0.9981412,0.0001245084,0.0001432818,0.00004445453,0.000005247676,0.00002088868,7.545602e-7,0.0002226957],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00245821,"threshold_uncertainty_score":0.008223534,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4411046742","doi":"10.1007/s40259-025-00727-z","title":"Beyond Cost: Observations on Clinical and Patient Benefits of Biosimilars in Real-World Settings","year":2025,"lang":"en","type":"review","venue":"BioDrugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Arthritis Research Centre of Canada","funders":"Sandoz; Diakonhjemmet","keywords":"Biosimilar; Real world evidence; Intensive care medicine; Medicine; Pharmacotherapy; Internal medicine","authors":[{"name":"Tore K Kvien","is_ca":false},{"name":"Neil Betteridge","is_ca":false},{"name":"Ines Brückmann","is_ca":false},{"name":"Wolfram Bodenmüller","is_ca":false},{"name":"Galyna Bryn","is_ca":false},{"name":"Silvio Danese","is_ca":false},{"name":"João Gonçalves","is_ca":false},{"name":"Zorana Maravic","is_ca":false},{"name":"Carter Thorne","is_ca":true},{"name":"Laura Wingate","is_ca":false},{"name":"Paul Cornes","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1159401178690415,"gpt":0.3997444058284289,"spread":0.2838042879593874,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004981851,0.0004885047,0.001058737,0.001397151,0.0001892659,0.002107095,0.0007105234,0.00179367,0.005331283],"category_scores_gemma":[0.01385863,0.0002004147,0.001103812,0.002298403,0.0009489897,0.002107144,0.0008232896,0.002810215,0.0007068096],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001301547,"about_ca_system_score_gemma":0.001600568,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008524164,"about_ca_topic_score_gemma":0.0009902192,"domain_scores_codex":[0.9977868,0.0009205485,0.0002913018,0.0002332773,0.0006704818,0.00009757768],"domain_scores_gemma":[0.9887179,0.009062322,0.001028264,0.0001624527,0.0008933645,0.0001356609],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005627198,0.0001057494,0.0009403808,0.03009019,0.0006285135,0.0002831798,0.0002297375,0.0009960915,0.001458621,0.0306265,0.01653056,0.9175478],"study_design_scores_gemma":[0.0002351341,0.0009360085,0.00760253,0.0297656,0.001130093,0.003444317,0.0005493005,0.0004122601,0.00247085,0.01911287,0.9342487,0.00009239755],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008330725,0.9945973,0.0002812509,0.001733745,0.000169585,0.000008103784,0.00004326866,0.000003920955,0.002329762],"genre_scores_gemma":[0.01594692,0.9807994,0.0005070297,0.001643105,0.0004884013,0.00002961422,0.00006028283,0.000006176589,0.000519061],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005331283,"threshold_uncertainty_score":0.02634686,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4407922422","doi":"10.1007/s40259-025-00709-1","title":"Biosimilar Policies and Their Impact on Market Penetration of Adalimumab, Etanercept and Infliximab: A Policy Synthesis and Descriptive Analysis in 13 OECD Countries","year":2025,"lang":"en","type":"article","venue":"BioDrugs","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia Hospital; University of Calgary; University of British Columbia; University of Toronto; Providence Health Care","funders":"Canadian Institutes of Health Research; National Research Foundation of Korea; Michael Smith Health Research BC","keywords":"Biosimilar; Infliximab; Adalimumab; Etanercept; Descriptive statistics; Medicine; Antirheumatic Agents; Pharmacology; Business; Rheumatoid arthritis; Internal medicine; Tumor necrosis factor alpha","authors":[{"name":"Alexander C. T. Tam","is_ca":true},{"name":"Jasleen Badesha","is_ca":true},{"name":"Daphne Guh","is_ca":true},{"name":"Nick Bansback","is_ca":true},{"name":"Kevin J. Peter","is_ca":true},{"name":"Aidan Hollis","is_ca":true},{"name":"Paul Grootendorst","is_ca":true},{"name":"Sang-Cheol Bae","is_ca":false},{"name":"Aslam H. Anis","is_ca":true},{"name":"Wei Zhang","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01123814212673292,"gpt":0.2880359146218365,"spread":0.2767977724951036,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004034895,0.0003103832,0.0005188848,0.005025519,0.0004354861,0.003775442,0.0003525378,0.0007355907,0.003266263],"category_scores_gemma":[0.01678898,0.0002542766,0.001297356,0.01213119,0.00112634,0.001443409,0.001542646,0.0009803757,0.0002550334],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00624601,"about_ca_system_score_gemma":0.003597362,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03906151,"about_ca_topic_score_gemma":0.01651587,"domain_scores_codex":[0.9946096,0.002267796,0.0005519733,0.0003353405,0.00105755,0.001177796],"domain_scores_gemma":[0.9645481,0.02318505,0.009226894,0.0004457167,0.002102977,0.0004912565],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002509787,0.0003401382,0.8730378,0.002564118,0.001558228,0.0009511859,0.00299387,0.0114822,0.0004872455,0.03741775,0.005854476,0.06080325],"study_design_scores_gemma":[0.0001177487,0.0003940115,0.9334493,0.002035364,0.001349061,0.000504345,0.0148377,0.002453864,0.00146105,0.003490187,0.03983783,0.00006948908],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.9391308,0.02457594,0.0007995826,0.002409112,0.00004682718,0.00008992323,0.01242068,0.00002933093,0.02049777],"genre_scores_gemma":[0.9884008,0.008174678,0.0002756805,0.0003446316,0.00001905409,0.00008234676,0.002031611,0.00001294414,0.0006582153],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.03906151,"threshold_uncertainty_score":0.07766831,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4362507438","doi":"10.1007/s40259-023-00592-8","title":"Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor","year":2023,"lang":"en","type":"article","venue":"BioDrugs","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Alberta","funders":"ZonMw","keywords":"Medicine; Internal medicine; Rheumatoid arthritis; Etanercept; Cohort; Adverse effect; Adalimumab; Infliximab; Rituximab; Discontinuation; Disease; Pediatrics","authors":[{"name":"Jette A. van Lint","is_ca":false},{"name":"Naomi T. Jessurun","is_ca":false},{"name":"Sander W. Tas","is_ca":false},{"name":"Harald E. Vonkeman","is_ca":false},{"name":"Martijn B. A. van Doorn","is_ca":false},{"name":"Frank Hoentjen","is_ca":true},{"name":"Michael T. Nurmohamed","is_ca":false},{"name":"Eugène van Puijenbroek","is_ca":false},{"name":"Bart J. F. van den Bemt","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1220145560077484,"gpt":0.3517712687053033,"spread":0.229756712697555,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001873227,0.0001585677,0.000404857,0.0006252892,0.0001974646,0.0004748914,0.0002518537,0.0003284458,0.001196297],"category_scores_gemma":[0.007664327,0.0001276596,0.0003963499,0.001287668,0.0001536692,0.0003117387,0.0004408543,0.0002759616,0.0002376117],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000651714,"about_ca_system_score_gemma":0.000423082,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008776056,"about_ca_topic_score_gemma":0.0101235,"domain_scores_codex":[0.9982848,0.0007665659,0.0002932362,0.0001778159,0.0003852488,0.00009235194],"domain_scores_gemma":[0.9930112,0.00158785,0.004325492,0.0002713464,0.0004546947,0.0003495112],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00075225,0.00009630576,0.9882758,0.0001193024,0.0001431246,0.000137057,0.0005264069,0.00006935321,0.0003224385,0.00001936474,0.0008240898,0.00871441],"study_design_scores_gemma":[0.0000856941,0.0002607733,0.9969068,0.00004083999,0.0000556704,0.0003817461,0.0002153832,0.0001519963,0.0000979933,0.000008922226,0.001788446,0.000005838083],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9949366,0.0009446885,0.0001402234,0.00008874188,0.000005414472,0.00006295388,0.002880842,0.000003596247,0.0009368993],"genre_scores_gemma":[0.9943932,0.000691981,0.0002441598,0.0001001142,0.00001406476,0.0001374984,0.004145539,0.000005491128,0.0002678999],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008776056,"threshold_uncertainty_score":0.01744998,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2007886942","doi":"10.2165/00063030-200013040-00004","title":"Use of Thalidomide in Dermatological Indications","year":2000,"lang":"en","type":"article","venue":"BioDrugs","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University","funders":"","keywords":"Thalidomide; Medicine; Adverse effect; Immunology; Pharmacology; Drug; Disease; Internal medicine; Multiple myeloma","authors":[{"name":"V. Kontogiannis","is_ca":true},{"name":"Richard J. Powell","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07712116623729452,"gpt":0.3360419291086052,"spread":0.2589207628713107,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003369419,0.0001269195,0.0003164339,0.0005486863,0.0002915181,0.0003616483,0.0001999984,0.0003937216,0.002555632],"category_scores_gemma":[0.0007718767,0.00005524653,0.0003759549,0.0004362313,0.0001546642,0.0001721653,0.000168141,0.0005242624,0.0004135068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004265983,"about_ca_system_score_gemma":0.0002853732,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000932868,"about_ca_topic_score_gemma":0.001463102,"domain_scores_codex":[0.9998467,0.00004846889,0.00001387153,0.0000182276,0.00004472162,0.00002802998],"domain_scores_gemma":[0.9997515,0.0001032119,0.0000646457,0.00001567827,0.00002716656,0.00003788676],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.004770974,0.0007793612,0.03375887,0.001470423,0.0004655315,0.007853103,0.0004012893,0.0004613597,0.1588234,0.003020854,0.006070618,0.7821242],"study_design_scores_gemma":[0.00156911,0.01885314,0.1792997,0.001491694,0.001713418,0.09161043,0.0006293755,0.001461606,0.2564152,0.002024632,0.4448479,0.00008379269],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.6229297,0.3101966,0.004218441,0.003935994,0.0007492094,0.0001314267,0.0004609262,0.0001402097,0.05723746],"genre_scores_gemma":[0.9579974,0.03320808,0.001708792,0.0009566848,0.0003054642,0.00003940171,0.0002040136,0.00001946256,0.005560619],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.002555632,"threshold_uncertainty_score":0.008549452,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4200032396","doi":"10.1007/s40259-021-00512-8","title":"A Clinical Prediction Model to Determine Probability of Response to Certolizumab Pegol for Crohn’s Disease","year":2021,"lang":"en","type":"article","venue":"BioDrugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"UCB Pharma; National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Certolizumab pegol; Medicine; Calprotectin; Internal medicine; Confidence interval; Crohn's disease; Odds ratio; Area under the curve; Population; Placebo; Gastroenterology; Pharmacokinetics; Inflammatory bowel disease; Disease; Adalimumab","authors":[{"name":"Pavine Lefèvre","is_ca":false},{"name":"Parambir S. Dulai","is_ca":false},{"name":"Zhongya Wang","is_ca":false},{"name":"Leonardo Guizzetti","is_ca":false},{"name":"Brian G. Feagan","is_ca":true},{"name":"Anca Lucia Pop","is_ca":false},{"name":"Mohamed Yassine","is_ca":false},{"name":"Lisa M. Shackelton","is_ca":false},{"name":"Vipul Jairath","is_ca":true},{"name":"William J. Sandborn","is_ca":false},{"name":"Niels Vande Casteele","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03376399519034329,"gpt":0.3145580637676515,"spread":0.2807940685773082,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002793435,0.0007868981,0.001269364,0.001265634,0.0003388324,0.001280751,0.0008821217,0.001229764,0.003027642],"category_scores_gemma":[0.009707935,0.0003920494,0.0008603754,0.0005355163,0.0003277027,0.000508228,0.0005409693,0.00125136,0.0007591517],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006469563,"about_ca_system_score_gemma":0.001017418,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006910642,"about_ca_topic_score_gemma":0.00324665,"domain_scores_codex":[0.9993148,0.0002749419,0.0000587859,0.0001626548,0.00009809828,0.00009082711],"domain_scores_gemma":[0.9898319,0.008593773,0.0005710559,0.0001612013,0.0005311822,0.0003107012],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.002547884,0.0007391245,0.2320299,0.0001379769,0.0005989227,0.0008031936,0.00009572223,0.6532598,0.001225671,0.002769087,0.008124491,0.09766827],"study_design_scores_gemma":[0.00005515251,0.0001245302,0.00673287,0.00001210809,0.00007163628,0.0001124141,0.00001213878,0.9913877,0.0001359586,0.001052917,0.0002934634,0.000009222536],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7525274,0.001904919,0.2262769,0.005897974,0.0003761933,0.0002998271,0.004944946,0.001223449,0.006548466],"genre_scores_gemma":[0.987958,0.0001987481,0.008407843,0.0002072422,0.0001256003,0.000107787,0.001415154,0.00001883376,0.001560806],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006910642,"threshold_uncertainty_score":0.01477325,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}